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Abstract
Overlap between treatment groups is required
for non-parametric estimation of causal effects.
If a subgroup of subjects always receives the
same intervention, we cannot estimate the ef-
fect of intervention changes on that subgroup
without further assumptions. When overlap
does not hold globally, characterizing local
regions of overlap can inform the relevance
of causal conclusions for new subjects, and
can help guide additional data collection. To
have impact, these descriptions must be inter-
pretable for downstream users who are not ma-
chine learning experts, such as policy makers.
We formalize overlap estimation as a problem
of finding minimum volume sets subject to
coverage constraints and reduce this problem
to binary classification with Boolean rule clas-
sifiers. We then generalize this method to
estimate overlap in off-policy policy evalua-
tion. In several real-world applications, we
demonstrate that these rules have comparable
accuracy to black-box estimators and provide
intuitive and informative explanations that
can inform policy making.
1 INTRODUCTION
To accurately estimate the causal effect of an inter-
vention, it is essential that intervention alternatives
have been observed in comparable contexts, i.e., that
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there is overlap between the distributions of individu-
als receiving each intervention (Rosenbaum and Rubin,
1983; D’Amour et al., 2017). In randomized experi-
ments, overlap is guaranteed for the study population
by randomizing the intervention. However, this is not
the case in observational studies where interventions
are chosen according to an existing, in some cases de-
terministic, policy. In such settings, overlap may hold
only for an unidentified subset of cases, with the causal
effect being unidentifiable outside of this subset. We
motivate our paper with the following use cases:
Scenario 1: From study to policy. When researchers
publish the findings of a clinical trial, they also share
the eligibility criteria (e.g., Age ≥ 18, Serum M protein
≥ 1g/dl or Urine M protein ≥ 200 mg/24 hrs, Recent
diagnosis (National Cancer Institute, 2012)) and cohort
statistics in order to characterize the cohort of study
subjects. This gives policy makers means to assess the
external validity of the results, i.e., to whom the results
apply. We seek to provide the same for observational
studies, with our algorithms producing an interpretable
description of subjects with treatment group overlap.
Scenario 2: Evaluating guidelines. There are over
471 different guidelines for how to manage hyperten-
sion (Benavidez and Frakt, 2019). We could evaluate
these—and new guidelines—using off-policy evaluation
methods (Precup et al., 2000) on observational data
derived from electronic medical records. Off-policy
evaluation of a guideline is only possible on subsets of
the population where there is some probability that the
guideline was followed (which we will also call overlap).
The estimated policy value should be accompanied by
a description of the validity (overlap) region.
Beyond causal estimation, overlap is of interest in many
other branches of machine learning: In domain adapta-
tion, the overlap between source and target domains
is the set of inputs for which we can expect a trained
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Figure 1: Overlap Oα, between treatment groups with
joint support Sα. A point x∗ has group propensity ηt
bounded away from 0 and 1, but is outside of Oα,.
model to transfer well (Ben-David et al., 2010; Johans-
son et al., 2019); In classification, overlap between in-
puts with different labels signifies regions that are hard
to classify; In algorithmic fairness (Dwork et al., 2012),
overlap between protected groups may shed light on
disparate treatment of individuals from different groups
who are otherwise comparable in task-relevant charac-
teristics; In reinforcement learning, lack of overlap has
been identified as a failure mode for deep Q-learning
using experience replay (Fujimoto et al., 2019).
Our main contributions are as follows: (i) We propose
desiderata in overlap estimation, and note how existing
methods fail to satisfy them. (ii) We give a method for
interpretable characterization of distributional overlap,
which satisfies these desiderata, by reducing the prob-
lem to two binary classification problems, and using
a linear programming relaxation of learning optimal
Boolean rules. (iii) We give generalization bounds for
rules minimizing empirical loss. (iv) We demonstrate
that small rules often perform comparably to black-box
estimators on a suite of real-world tasks. (v) We evalu-
ate the interpretability of rules for describing treatment
group overlap in post-surgical opioid prescription in a
user study with medical professionals. (vi) We show
how a generalized definition and method applies to
policy evaluation and apply it to describing overlap in
policies for antibiotic prescription.
2 RELATED WORK
Treatment group overlap is a central assumption in the
estimation of causal effects from observational data.
Comparing group-specific covariate bounds and lower-
order moments is a common first step in assessing
overlap (Rosenbaum, 2010; Zubizarreta, 2012; Fogarty
et al., 2016) but fails to identify local regions of overlap
when they exist (see the example of Oα, in Figure 1).
An alternative is to estimate the treatment propensity—
the probability that a subject was prescribed treatment.
Treatment propensities bounded away from 0 and 1 at
a point X indicates that treatment groups overlap at
X (Rosenbaum and Rubin, 1983; Li et al., 2018).
In studies with partial overlap, it is common to restrict
the study cohort by thresholding treatment propen-
sity or discarding unmatched subjects after applying
matching methods (Rosenbaum, 1989; Iacus et al.,
2012; Kallus, 2016; Visconti and Zubizarreta, 2018).
For example, Crump et al. (2009) proposed an optimal
propensity threshold that minimizes the variance of the
estimated average treatment effect on a sub-population.
However, neither propensity thresholding nor matching
are sufficient for guiding policy in new cases: they do
not provide a self-contained, interpretable description
of where treatment groups overlap within the study,
nor do they provide insight into external validity by
describing the limits of the study cohort.
Fogarty et al. (2016) address the first concern above
by learning “interpretable study populations” through
identifying the largest axis-aligned box that contains
only subjects with bounded propensity. However, this
approach is very limited in capacity and does not ad-
dress external validity. For this reason, we strive to
provide interpretable descriptions of overlap, both in
terms of treatment propensity and the study support.
Rule-based models have been considered in classifica-
tion tasks (Rivest, 1987; Angelino et al., 2017; Yang
et al., 2017; Lakkaraju et al., 2016; Wang et al., 2017;
Dash et al., 2018; Freitas, 2014; Wang and Rudin, 2015),
subgroup discovery (Herrera et al., 2011) and density
estimation (Ram and Gray, 2011; Goh and Rudin, 2015)
but have to the best of our knowledge not been applied
or tailored to support or overlap estimation.
3 DEFINING OVERLAP
We address interpretable description of population over-
lap. Our primary motivation is to aid policy making
based on observational studies, the success of which
relies on understanding and communicating the stud-
ies’ validity region—the set of cases for which there is
evidence that a particular policy decision is preferable.
We identify the following desiderata for descriptions of
overlap: (D.1) They cover regions where all populations
(treatment groups) are well-represented; (D.2) They
exclude all other regions, including those outside the
support of the study (see Figure 1); (D.3) They can
be expressed using a small set of simple rules. Next,
we define overlap according to (D.1) and (D.2). We
address (D.3) in Section 4.
Let subjects i = 1, ...,m be observed through samples
(xi, ti) of covariates X ∈ X ⊆ Rd and a group indicator
T ∈ T . In our running example, X represents patient
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attributes and T their treatment. We assume that
subjects are independently and identically distributed
according to a density p(X,T ), and that X is bounded.
Let pt(X) := p(X | T = t) denote the covariate density
of group t ∈ T and ηt(x) := p(T = t | X = x) the
propensity of membership in group t ∈ T for subjects
with covariates x ∈ X . We denote the probability mass
of a set S ⊆ X under p by P (S) := ∫
x∈S dp and the
support of p by supp(p) := {x ∈ X : p(x) > 0}.
In the common case of two groups, T = {0, 1}, over-
lap is typically defined as either a) the intersection
of supports, supp(p0) ∩ supp(p1), or b) the set of co-
variate values for which all group propensities ηt are
bounded away from zero (D’Amour et al., 2017; Li
et al., 2018). We let B denote this latter set of val-
ues with -bounded propensity for a fixed parameter
 ∈ (0, 1) and an arbitrary set of groups T ,
B := {x ∈ X ;∀t ∈ T : ηt(x) > } . (1)
Neither B nor the support intersection fully capture
our desired notion of overlap: The former does not sat-
isfy (D.2) since a point may have bounded propensity
(true or estimated) but lie outside the population sup-
port supp(p) (see Figure 1). Note that interpretable
description alone does not address this. The latter
is non-informative for variables with infinite support
(e.g., a normal random variable), and even with finite
support, we may wish to exclude distant outliers.
Our preferred definition of overlap combines the re-
quirement of bounded propensity with a generalization
of support called α-minimum-volume sets (Schölkopf
et al., 2001). Let C be a set of measurable subsets of
X , let V (C) denote the volume of a set C ∈ C. An
α-minimum-volume set Sα of p is then
Sα := arg min
C
{V (C) ;P (C) ≥ α,C ∈ C} , (2)
with S1 = supp(p). For α < 1, Sα is not always
unique, but the intersection S of two α-MV sets has
mass P (S) ≥ 2α − 1. In this work, we let α < 1 in
order to handle distributions with infinite support and
unwanted outliers, and refer to Sα as the support of p.
We define the α, -overlap set, for α,  ∈ (0, 1), to be
Oα, := Sα ∩ B . (3)
We define the problem of overlap estimation under defi-
nition (3) as characterizing the set Oα, given thresholds
α and . In line with (D.3), these characterizations
should be useful in policy making, and interpretable
by domain experts, at small cost in accuracy. For nota-
tional convenience, we sometimes leave out superscripts
from Sα,B and Oα,, assuming that α,  are fixed.
Remark. Defining overlap instead as the intersection
of group-specific α-MV sets is feasible, but scales poorly
with |T |; it does not facilitate the generalization to
policy evaluation described below; and the intersection
of many descriptions may be hard to interpret.
3.1 Generalization to Policy Evaluation
The definition of B in (1) is motivated by causal ef-
fect estimation—comparison of outcomes under two or
more alternative interventions. We may instead be in-
terested in policy evaluation, which involves estimating
the expected outcome under a conditional intervention
pi, which assigns a treatment t to each x following a
conditional distribution pi(T |X) (Precup et al., 2000).
To perform this evaluation, we only require that the
propensity p(T |X) of observed treatments be bounded
away from zero for treatments which have non-zero
probability under pi. To describe the inputs for which
this is satisfied, we generalize B to be a function of
the target policy pi,
B(pi) := {x ∈ X ;∀t : pi(t | x) > 0 : ηt(x) > } . (4)
More details are given in the supplement regarding the
use of OverRule in this setting.
4 OVERRULE: BOOLEAN RULES
FOR OVERLAP
We propose OverRule1, an algorithm for identifying the
overlap region O in (3) by first estimating the α-MV
support set S (2) and then the bounded-propensity
set B (1) restricted to S, thereby satisfying desider-
ata (D.1)–(D.2). We aim to fulfill desideratum (D.3) by
using Boolean rules—logical formulae in either disjunc-
tive (DNF) or conjunctive (CNF) normal form—which
have received renewed attention because of their in-
terpretability (Dash et al., 2018; Su et al., 2016). See
Figures 3–4 for examples of learned rules. OverRule
proceeds in the following steps:
(i) Fit α-MV set Sˆα of p(X) using Boolean rules
(ii) Fit model of group propensity ηˆ(·) over Sˆα and let
b˜(x) =
∏
t∈T 1[ηˆt(x) > ] define membership in B˜
(iii) Approximate B˜ using Boolean rules to yield Bˆ
and estimate overlap region by Oˆα, = Bˆ ∩ Sˆα.
In this section, we demonstrate how steps (i) & (iii) can
be reduced to binary classification. This enables us to
exploit the many existing methods for rule-based classi-
fication (Freitas, 2014) to improve the interpretability
of Oˆ. Finally, we give results bounding the generaliza-
tion error of estimates of both S and S ∩ B.
1Code available at https://github.com/clinicalml/
overlap-code
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Remark. It was observed in evaluations with a medi-
cal practitioner that fitting rules for S and B separately
improved interpretability as it makes clear which rules
apply to which task and prevents the bulk of the rules
from being consumed by one of the two tasks.
4.1 Estimation of Sα as Binary Classification
In the first step of OverRule, we learn a Boolean rule
to approximate the α-MV set Sα of the marginal dis-
tribution p(X) by reducing the problem to binary clas-
sification between observed samples D := {xi}mi=1 and
uniform background samples. For clarity, we focus only
on DNF rules—disjunctions of conjunctive clauses such
as (Age < 30 ∧ Female) ∨ (Married). As pointed out
by Su et al. (2016), a CNF rule can be learned by
swapping class labels and fitting a DNF rule.
We adapt previous notation and let C be a class of
candidate α-MV sets C corresponding to Boolean rules,
i.e., each C consists of the points in X that satisfy a rule.
We will often not distinguish between a rule and its
corresponding set C and thus will speak of the “volume”
of a rule or clause. We aim to solve a normalized and
regularized version of the α-MV problem in (2),
arg min
C∈C
Q(C) := V¯ (C)
Volume
+ R(C) s.t.
Regularization
P (C) ≥ α
Coverage
(5)
where the volume V¯ (C) = V (C)/V (X ) ∈ [0, 1] is nor-
malized to that of X . We assume that the regulariza-
tion term R(C) controls complexity by placing penalties
λ0 on each clause in the rule and λ1 on each condi-
tion in a clause. Thus, for a Boolean rule with clauses
k = 1, . . . ,K, each with pk conditions, we have2
R(C) = Kλ0 + λ1
K∑
k=1
pk. (6)
It is also assumed that the trivial “all-true” and “all-
false” rules have complexity R(C) = 0.
The volume V¯ (C) may be difficult to compute repeat-
edly during optimization and C is often too large to
allow pre-computation of V¯ (C) for all C. In particular,
for DNF rules, each C is a union of potentially several
overlapping clauses (see Figures 3–4 or the illustration
in the supplement); even if the volume spanned by
each clause is quick to compute on the fly, the overall
volume may not be. As an alternative, the normalized
volume V¯ (C) can be estimated by means of uniform
samples {xm+1, . . . , xm+n} over X . Let U be the index
set of these uniform samples. Then, 1n
∑
i∈U 1[xi ∈ C]
is distributed as a scaled binomial random variable
2It is possible to generalize (6) to place different penalties
on different conditions but we adopt (6) for simplicity.
with mean V¯ (C) and variance V¯ (C)(1− V¯ (C))/n. Theo-
rem 1 below provides guidance in selecting the number
of uniform samples n to ensure a good estimate.
Given the above empirical estimator of volume, we
reduce problem (5) to a classification problem between
the marginal density p(X) and a uniform distribution
over X . This reduction was also mentioned in the
conclusion of Scott and Nowak (2006). We also re-
place the probability mass constraint with its empirical
version over D with I = {1, . . . ,m}. The result is a
Neyman-Pearson-like classification problem with a false
negative rate constraint of 1− α (instead of the usual
false positive constraint), as given below.
Sˆ := arg min
C
1
|U|
∑
i∈U
1[xi ∈ C] +R(C)
subject to
∑
i∈I
1[xi ∈ C] ≥ αm .
(7)
The following theorem bounds the regret of the min-
imizer of (7) with respect to (5) and is proven in the
supplement. The assumption of binary variables sim-
plifies the analysis and is not a fundamental limitation.
Theorem 1. Let q∗(α) denote the minimum regular-
ized volume attained in (5) over the class of DNF rules
with probability mass α. Assume that a) the regular-
ization R follows (6) with fixed parameters λ0, λ1, b)
all variables Xj are binary-valued, and c) the class C
is restricted to rules satisfying necessary conditions of
optimality for (5) (see Lemmas in the supplement).
Then with probability greater than 1− 2δ, the empirical
estimate Sˆ in (7) satisfies
Q(Sˆ) ≤ q∗(α+ m) + 2n and P (Sˆ) ≥ α− m,
where m =
√
λ−11 log(2d)+b1+log2 λ−11 c log λ−11 +log(4/δ)
2m
and n is defined analogously.
Remark. The error term m bounds the amount by
which the probability constraint may be violated and
contributes q∗(α+ m)− q∗(α) to the possible regret.
Given the number of data samples m, penalty λ1 (λ0
does not appear in this simplified bound) could be
chosen to keep m small, although user preferences
for rule complexity are likely to be more important
in setting λ0, λ1. Given λ1, the number of uniform
samples n could in turn be chosen to reduce n. Note
that m, n are largely controlled by λ1 and depend
only logarithmically on the dimension d.
4.2 Estimation of B as Binary Classification
To estimate the set B of inputs with bounded group
propensity ηt(X) := p(T = t | X), we follow in the tra-
dition of using black-box (potentially non-parametric)
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estimators of propensity to identify overlapping or bal-
anced cohorts in the study of causal effects (Crump
et al., 2009; Fogarty et al., 2016). This is typically
done by fitting a classifier (e.g., logistic regression) for
predicting T given X, and letting ηˆt(x) be the esti-
mated probability of class t for input x. Given such an
estimate, we assign a label b˜i to each data point xi ∈ D
indicating significant propensity for every group,
∀i ∈ [m] : b˜i =
∏
t∈T
1[ηˆt(xi) ≥ ] . (8)
Let B˜ = {xi : b˜i = 1}. Similar to the case of Sα, we
may now reduce estimation of B to binary classifi-
cation. Given Sˆ, the minimizer of (7), we again set
up a Neyman-Pearson-like classification problem, now
regarding the intersection Sˆ ∩ B˜ as the positive class:
Bˆ := arg min
C
1
|Sˆ \ B˜|
∑
i:xi∈Sˆ\B˜
1[xi ∈ C] +R(C) (9)
subject to
∑
i:xi∈Sˆ∩B˜
1[xi ∈ C] ≥ β|Sˆ ∩ B˜| .
The sets Sˆ \ B˜ and Sˆ ∩ B˜ are defined by the solution
to (7) and the base estimator (8). To accommodate
the policy evaluation setting described in Section 3,
we can modify the pseudo-labels defined in (8) to be
b˜i(pi) =
∏
t∈pi(xi) 1[pˆ(T = t | X = xi) ≥ ], where
pi(xi) := {t : pi(t|xi) > 0}, and solve (9) using B˜(pi) =
{xi : b˜i(pi) = 1} in place of B˜. The resulting full
procedure is given in the supplement.
Generalization of the final estimator. In the sup-
plement, we state and prove a theorem bounding the
generalization error of our final estimator, Oˆ = Sˆ ∩ Bˆ.
It shows that for good base estimators Sˆ, B˜, the error
of Oˆ with respect to the true overlap O is dominated
by its error with respect to the base estimators. Hence,
practitioners may make an informed tradeoff between
accuracy and interpretability based on this metric.
4.3 Optimizing Boolean Rules
Next, we describe a procedure for optimizing (7) over
a class C of Boolean DNF rules. The same procedure
also solves (9).
We assume that base features X have been binarized
to form literals such as (Age > 30) or (Sex = Female),
as is standard in e.g. decision tree learning. A con-
junction may thus be represented as the product of
binary indicators of these literals. We let K index the
set of all possible (exponentially many) conjunctions of
literals, e.g. (Age > 30)∧Female. Then, for k ∈ K, let
aik ∈ {0, 1} denote the value taken by the k-th conjunc-
tion at sample xi. Let the DNF rule be parametrized
by r ∈ {0, 1}|K| such that rk = 1 indicates that the
k-th conjunction is used in the rule.
Define an error variable ξi for i in U ∪ I representing
the penalty for covering or failing to cover point i,
depending on its set membership. Then, problem (7)
may be reformulated as follows,
minimize
r
1
|U|
∑
i∈U
ξi +R(r) (10)
subject to

rk ∈ {0, 1}, k ∈ K,
ξi ≥ 1−
∑
k∈K
aikrk, ξi ≥ 0, i ∈ I,∑
i∈I
ξi ≤ (1− α)m
ξi = max
k∈K
(aikrk), i ∈ U .
Problem (10) is an IP with an exponential number of
variables and is intractable as written. We follow the
column generation approach of Dash et al. (2018) to
effectively manage the large number of variables and
solve (10) approximately. As in that previous work,
we bound from above the max in the last constraint of
(10) with the sum (Hamming loss instead of zero-one
loss) as it gives better numerical results. The choice of
regularization in (6) implies R(r) =
∑
k∈K λkrk with
λk = λ0 + λ1pk. Thus the objective becomes linear in
r,
∑
k∈K
(
1/|U|∑i∈U aik + λk) rk, and the ξi, i ∈ U
constraints are absorbed into the objective. We then
follow the overall procedure in (Dash et al., 2018) of
solving the linear programming (LP) relaxation, using
column generation to add variables only as needed.
We make the following departures from Dash et al.
(2018). As noted, (10) has a constraint on false negative
rate instead of a corresponding objective term and
a complexity penalty R(r) while Dash et al. (2018)
use a constraint. As a result, the LP reduced costs,
needed for column generation, are different. With dual
variables µi ≥ 0, i ∈ I corresponding to the ξi, i ∈ I
constraints in (10), the reduced cost of conjunction k is
now 1/|U|∑i∈U aik + λk −∑i∈I µiaik, which remains
a linear function of aik, allowing the same column
generation method to be used. We also avoid the
need for an IP solver as used in Dash et al. (2018)
by a) solving the column generation problem using a
beam search algorithm from (Wei et al., 2019), and
b) restricting (10) to the final columns once column
generation terminates, converting to a weighted set
cover problem, and applying a greedy algorithm to
obtain an integer solution.
5 EXPERIMENTS
In our experiments, we seek to address the following
questions, while relating the performance of OverRule
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to that of MaxBox (MB) (Fogarty et al., 2016), which
is also designed to produce interpretable study popula-
tions. (i) Why is support estimation important?
In Section 5.1 we give a conceptual illustration using
the Iris dataset, where MaxBox returns a description
that empirically includes a large space outside of the
true overlap region. (ii) How well does OverRule
approximate the base estimators / true overlap
region? In Section 5.2 we use the Jobs (LaLonde,
1986) dataset to show that performance of OverRule
is comparable to that of the base estimators, and gen-
erally surpasses the performance of MaxBox. (iii) Do
the resulting rules yield any insights? We apply
OverRule to overlap estimation in two real-world clini-
cal datasets on (1) post-surgical opioid prescriptions,
and (2) policy evaluation in antibiotic prescriptions.
For the former, we conducted a user study with three
clinicians to interpret and critique the output, with
additional comparison to the output of MaxBox.
OverRule and MaxBox algorithms are both meta-
algorithms in the sense that they take (as input) labels
indicating whether each data point is in the overlap set.
To generate these labels, we use a variety of base over-
lap estimators: (i) Covariate Bounding Boxes: The
intersection of covariate (marginal) bounding boxes
(CBB), analogous to classical balance checks in causal
inference. The bounding boxes are selected to cover the
[(1−α)/2, (1 +α)/2] quantiles of the data. (ii) Propen-
sity Score Estimators: Standard propensity score es-
timators as described in (8) and Crump et al. (2009)
with logistic regression (PS-LR) or k-nearest neigh-
bors (PS-kNN) estimates of the propensity. These can
be viewed as a binary version of overlap weights (Li
et al., 2018). (iii) One-Class SVMs: One-Class Support
Vector Machines (OSVM) to first estimate conditional
supports and then use their intersection as overlap la-
bels. Details on hyperparameter selection and feature
binarization are given in the supplement, along with
general guidance on hyperparameter selection depend-
ing on user goals, from optimizing an observable metric
(e.g., accuracy w.r.t the base estimator), to generating
shorter rule sets, to exploring structure in the data.
5.1 Illustrative Example: Iris
We use the Iris dataset to illustrate the importance
of combining explicit support estimation (lacking in
MaxBox) with an interpretable characterization of the
overlap region (lacking in propensity score models). We
use OverRule to identify the overlap between members
of two species of Iris, as represented by their sepal
and petal dimensions. In Figure 2, we visualize the
estimates Oˆ learned using OverRule and MaxBox in
the space of sepal length and width. In contrast, the
coefficients of a logistic regression propensity score
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Figure 2: Overlap (orange stripes) between Versicolor
(blue circles) and Virginica (red triangles) species in the
Iris dataset as identified by OverRule (left) and MaxBox
(right) using the same base estimator of propensity.
Black stars indicate samples of the (unobserved) Setosa
species. We see that MaxBox identifies several of the
Setosa samples as being in the overlap set, despite it
being outside of the support of the observed data.
AND NOT Rule S.4:
Hispanic
and RE75 > $26k
Age ≤ 27 y.o
and ¬ Degree
Rule B.1:
Support rules ෡𝓢
Overlap rules ෡𝓑
AND NOT Rule S.3:
¬Married
and RE75 > $32k
NOT Rule S.1:
Yrs. Edu. > 11
and ¬ Degree
and RE74 > $33k
AND NOT Rule S.2:
Yrs. Edu. > 11
and ¬ Degree
and RE75 > $32k
AND NOT Rule S.6:
RE74 > $33k
and RE75 in (0, $26k] 
AND NOT Rule S.7:
RE74 in (0, $26k]
and RE75 > $32k 
AND NOT Rule S.5:
Black
and Hispanic
Black
and ¬Married
OR Rule B.2:
RE75 ≤ $10k
and ¬Married
OR Rule B.3:
Figure 3: OverRule description of the overlap region
O in the Jobs dataset learned using the LR propensity
base estimator, achieving held-out balanced accuracy
of 0.88. ¬ indicates a negation, and CNF support
rules are given with rule-level negations applied for
readability. If none of the support rules (top) and any
of the overlap rules (bottom) apply, a subject is in O.
model, [−1.7,−1.5, 2.5, 2.6]> reveal very little about
which points lie in the overlap set.
5.2 Job Training Programs
In this section, we demonstrate that OverRule com-
pares favorably to MaxBox in terms of approximating
both the derived overlap labels (using a base estima-
tor), as well as the “ground truth” overlap labels in a
real dataset. To do so, we use data from a famous trial
performed to study the effects of job training (LaLonde,
1986; Smith and Todd, 2005), in which eligible US cit-
izens were randomly selected into (T = 1), or left
out of (T = 0) job training programs. The RCT
(E = 1), which satisfies overlap by definition, has since
been combined with non-experimental control samples
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Table 1: Overlap estimation in Jobs. Balanced accu-
racy (Acc), false positive rate (FPR), false negative rate
(FNR), and number of literals (L) with standard devi-
ations over 5-fold CV. MB and OR indicate MaxBox
and OverRule. MB did not run with CBB.
Acc FPR FNR L
Baselines (base estimators):
CBB 0.75± 0.02 0.12± 0.01 0.38± 0.03 —
OSVM 0.82± 0.01 0.22± 0.03 0.14± 0.02 —
PS-k-NN 0.90± 0.02 0.14± 0.02 0.05± 0.02 —
PS-LR 0.96± 0.01 0.10± 0.01 0.09± 0.03 —
MaxBox with base estimator:
OSVM 0.68± 0.01 0.09± 0.02 0.54± 0.01 16
PS-kNN 0.84± 0.01 0.03± 0.01 0.29± 0.02 16
PS-LR 0.80± 0.02 0.04± 0.01 0.35± 0.04 16
OverRule with base estimator:
CBB 0.83± 0.01 0.16± 0.01 0.19± 0.02 20
OSVM 0.84± 0.02 0.25± 0.03 0.07± 0.02 23
PS-kNN 0.89± 0.02 0.16± 0.02 0.06± 0.02 40
PS-LR 0.88± 0.02 0.15± 0.04 0.09± 0.01 21
(E = 0, T = 0), forming a larger observational set
(Jobs), to serve as a benchmark for causal effect esti-
mation (LaLonde, 1986). Here, we aim to characterize
the overlap between treated and control subjects.
Due to the trial’s eligibility criteria, the experimental
and non-experimental cohorts barely overlap; standard
logistic regression separates the experimental and non-
experimental groups with held-out balanced accuracy
of 0.96. Since all treated subjects were part of the ex-
periment, the experimental cohort perfectly represents
the overlap region. For this reason, we use the experi-
ment indicator E as ground truth for O, at the risk of
introducing a small number of false negatives. In stud-
ies of causal effects in this data, the following features
were included to adjust for confounding: Age, #Years
of education (Educ), Race (black/hispanic/other), Mar-
ried, No degree (NoDegr), Real earnings in 1974 (RE74)
and 1975 (RE75). These are the features X for which
we estimate overlap.
We present results in Table 1 and Figure 3, where
all balanced accuracies are w.r.t. the ground truth in-
dicator E. For the propensity base estimators, the
OverRule approximations achieve slightly lower bal-
anced accuracies than the base estimator, but with a
simpler description, while for the other base estimators
the accuracy is actually better. OverRule compares
favorably to MaxBox on balanced accuracy, although
MaxBox generally achieves a lower FPR, likely because
it does not try to retain a fixed fraction β of the over-
lap set. In the supplement, we show that the held-out
balanced accuracy quickly converges as the number of
literals in the rules increases and correlates strongly
with the quality by which the rule set approximates
the base estimator.
The learned support rules in Figure 3 demonstrate that
support estimation can find gaps in the dataset that are
intuitive, such as a lack of individuals with high income
but no degree (Rules S.1-2) or whose income changes
dramatically from 1974 to 1975 (Rules S.6-7). The
learned overlap rules conform to expectations, as the
eligibility criteria for the RCT allow only subjects who
were currently unemployed and had been so for most of
the time leading up to the trial—factors that correlate
with age and education (Rule B.1), previous income
(Rule B.3), and marital status (Rules B.2-3) (Smith
and Todd, 2005).
5.3 Post-surgical Opioid Prescriptions
Opioid addiction affects millions of Americans. Un-
derstanding the factors that influence the risk of ad-
diction is thus of great importance. To this end, Brat
et al. (2018) and Zhang et al. (2017) study the effect of
choices in opioid prescriptions on the risk of future mis-
use. Here, we study a group of post-surgical patients
who were given opioid prescriptions within 7 days of
surgery, replicating the cohort eligibility criteria of Brat
et al. (2018) using a subset of the MarketScan insurance
claims database. We compare groups of patients with
morphine milligram equivalent (MME) doses above and
below the 85th percentile in the cohort, MME=450.
Subjects were represented by basic demographics (age,
sex), diagnosis history, and procedures billed as surgi-
cal on the index date (not mutually exclusive). Cohort
statistics are given in the supplement. We fit three
models: An OverRule model (OR) using DNF support
rules and a random forest base estimator, a MaxBox
model (MB) (Fogarty et al., 2016) with the same base
estimator, and another OverRule model describing the
complement of O (OR-C). The balanced accuracies
of these models w.r.t. the base were 0.90 (OR), 0.77
(MB) and 0.92 (OR-C). Learning took 10 minutes for
OverRule (Python) and 7 minutes for MaxBox (R).
Other hyperparameter details are in the supplement.
In Figure 4, we summarize the rules learned by OR
which cover 27% of the overall population. MB learned:
(Musculoskeletal surg. ∧ ¬Mediastinum surg. ∧ ¬Male gen-
ital surg. ∧ ¬Maternity surg. ∧ ¬Lumbosacral spondylosis
without myelopathy) which covers 17% of patients. The
rules learned by OR-C are presented in the supplement.
To evaluate the interpretability of the output, we con-
ducted a qualitative user study through a moderated
discussion with three participants: two attending sur-
geons (P1 & P2) and a 4th year medical student (P3)
at a large US teaching hospital. Before seeing the out-
puts of any method, the participants were asked to give
their expectations for what to find in the overlap set.
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Rule S.1:
History: and Surgical procedure:¬ Injury of face and neck ¬ Endocrine system
and ¬ Unspecified septicemia and ¬ Mediastinum (thoracic cavity)
and ¬ Other injury of chest wall and ¬Auditory system
and ¬ Acute respiratory failure and Age ∈ [0, 64]
and ¬ Altered mental status 
Rule B.1:
Surgical procedure:
Musculoskeletal
or Rule B.2:
Age > 44
and Male
and Surgical procedure:
Cardiovascular
and ¬ Urinary system (e.g, bladder)
and ¬ Male genital system
or Rule B.3:
Surgical procedure:
Nervous (e.g., epidural)
and ¬ Maternity (e.g., C-section)
and ¬ Female genital system
or Rule B.4:
Age > 23
and Surgical procedure:¬ Maternity
and History:
Thoracic or lumbosacral 
neuritis or radiculitis
𝒪( = S.1 ∧ (B.1 ∨ B.2 ∨ B.3 ∨ B.4)Support rules 𝒮
Propensity overlap rules ℬ
Figure 4: OverRule description of post-surgical patients
likely to receive both high and low opioid doses. A
patient is in the overlap set if the support rule (top) ap-
plies and any propensity overlap rule (bottom) applies.
¬ indicates negation. The rules cover 27% of patients
with balanced accuracy of 0.90 w.r.t. the base estima-
tor. Surgical procedures are not mutually exclusive.
The participants expected that the overlap set would
mostly correspond to patients in the higher dose range,
as these patients are often considered also for smaller
doses, and that overlap would be driven largely by
surgery type. All participants expected Musculoskele-
tal and Cardiovascular surgery patients to be predom-
inantly in the higher dose group, and sometimes in
the lower, and one suggested that Maternity surgeries
(e.g., C-sections) would be only in the lower range.
These comments are all consistent with the findings of
OverRule, which identified all of these surgery types
as important. MaxBox identified only Musculoskeletal
surgery patients as overlapping. One participant ex-
pected history of psychiatric disease and Tobacco use
disorder to be predictive of higher prescription doses
for some patients, and thus overlap. Neither method
identified psychiatric disease, but Tobacco use disorder
was identified by OR-C as predictive (see supplement).
The participants found the support rules (Sˆ) output
by OR (Figure 4 top) intuitive. P1 stated that En-
docrine surgeries are not typically followed by opioid
prescriptions. They found the MaxBox and OR rule de-
scriptions easy to interpret, and discussion focused on
their clinical meaning. The first three propensity over-
lap rules B.1-B.3 were all consistent with expectation
as described above, with the caveat that Cardiovascu-
lar patients are not typically stratified by Urinary and
Genital surgeries. This was later partially explained by
catheters being billed as Urinary and P3 interpreted
this as a proxy for more severe Cardiovascular surgeries.
P1 pointed out the value in discovering such surprising
patterns that may be hidden in black-box analyses.
The OR-C rules were found hard to interpret due to
many double negatives (“excluded from exclusion”), but
were ultimately deemed clinically sound.
Remark: We noted that these support rules primarily
exclude individually rare features, in lieu of e.g., finding
that certain non-rare surgery types do not co-occur.
This motivated both (1) an empirical study (w/semi-
synthetic data) of how support rule hyperparameters
influence the recovery of these interactions, and (2) the
generation of new rules. Both are in the supplement.
5.4 Policy Evaluation of Antibiotic
Prescription Guidelines
Using the policy evaluation formulation of B(pi) (Sec-
tion 3.1), we apply OverRule to assess overlap for a
policy that follows clinical guidelines published by the
Infectious Disease Society of America (IDSA) for treat-
ment of uncomplicated urinary tract infections (UTIs)
in female patients (Gupta et al., 2011). Using medical
records from two academic medical centers, we apply
OverRule to a cohort of 65,000 UTI patients to test
whether it can recover a clinically meaningful overlap
set. From a qualitative perspective, we discussed the
resulting rules with an infectious disease specialist, who
verified that they have a clear clinical interpretation
as identifying primarily outpatient cases and uncompli-
cated inpatient cases, which are where the guidelines
are applied in practice. Detailed results (including
quantitative results) are given in the supplement.
6 CONCLUSION
We have presented OverRule—an algorithm for learning
rule-based characterizations of overlap between popu-
lations, or the inputs for which policy evaluation from
observational data is feasible. The algorithm learns to
exclude points that are marginally out-of-distribution,
as well as points where some population/policy has low
density. We gave theoretical guarantees for the gener-
alization of our procedure and evaluated the algorithm
on the task of characterizing overlap in observational
studies. These results demonstrated that our rule de-
scriptions often have similar accuracy to black-box es-
timators and outperform a competitive baseline. In an
application to study treatment-group overlap in post-
surgical opioid prescription, a qualitative user study
found the results interpretable and clinically meaning-
ful. Similar observations were made in an application
to evaluation of antibiotic prescription policies. Future
research challenges include investigating the scalability
of the method with the dimensionality of the input.
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Supplementary Material
The supplement is structured as follows:
• Guidance on hyperparameter selection: We
take a deeper dive into the impact of hyperparam-
eter selection on support and overlap estimation,
including an in-depth empirical evaluation with
concrete recommendations on how to set hyperpa-
rameters for support estimation given an a-priori
belief that higher-order intersections of variables
may be excluded from the cohort.
• Application to Policy Evaluation: We discuss
in more depth how the OverRule algorithm can
be applied to finding areas of sufficient coverage
for policy evaluation tasks.
• Additional experimental results: In addition
to providing additional detail on the experiments
presented in the main paper, we also present sev-
eral results that were only alluded to in the main
paper. This includes the detailed results for the
policy evaluation task (antibiotic prescription), as
well as additional rules learned for the opioids
prescription task.
• Theoretical results: We include proofs for our
theoretical results, as well as an additional Theo-
rem bounding the generalization error of our two-
stage estimator in terms of the error of the base
estimators.
In addition, to build further intuition for Boolean rules,
we illustrate a Boolean rule in the DNF form in a 2D
example in Figure S1.
Code for this paper can be found at https://github.
com/clinicalml/overlap-code
A Choosing Hyperparameters
A.1 Overview
Considering OverRule along with the base estimator,
there are a few distinct sets of hyperparameters to
choose
• Support Rules: The support rule estimation
task requires a specification of DNF versus CNF
form, a specification of α, λ0, λ1 used in the objec-
tive, and the number of samples to draw from the
reference measure.
• Base Estimator and Overlap Labels: In addi-
tion to the hyperparameters of the base estimator
itself, a threshold  must be chosen to generate
overlap labels
• Overlap Rules: These rules similarly require a
specification of DNF or CNF form, and specifica-
tion of β, λ0, λ1.
For the base estimator itself, the hyperparameters can
be tuned in the usual way using cross-validation using a
metric of interest (e.g., AUC). The choice of  is studied
in the existing literature (Crump et al., 2009) and
ultimately depends on the downstream causal inference
task, though  = 0.1 is sometimes considered as a rule
of thumb. For the support rules, we typically set the
number of reference measure samples to be as large as
computationally feasible.
For the overlap and support rules, the remaining hyper-
parameters can be chosen (1) by using cross-validation
to optimize for balanced accuracy (or some other met-
ric, like false positive rates) with respect to the overlap
labels or uniform background samples, (2) with some
other objective in mind, e.g., setting the λ parameters
to be large to discourage many rules, even if more rules
would increase accuracy, or (3) with the goal in mind
of choosing values (or exploring a range of values) most
likely to discover “interesting patterns” in the cohort.
We expand upon a concrete instance of this latter goal
in the remainder of this section, particularly as re-
gards hyperparameter selection for support estimation,
where extremely high accuracy is particularly easy to
achieve and is thus less informative for the purposes of
hyperparameter selection.
A.2 Choosing Support Hyperparameters to
highlight exclusions
Motivation: In the context of our motivating appli-
cations, the primary purpose of support estimation is
to identify regions where we do not have any (or have
very few) observations. For instance, if there are no
men in our dataset who also have cardiac arrhythmia1,
then this would be a clinically relevant fact that should
be highlighted. Thus, we would like to select hyperpa-
rameters which minimize our risk of overlooking these
types of exclusions.
In this section we give some guidance on how to select
hyper-parameters for support estimation with this par-
ticular goal in mind, based on synthetic and real-data
experiments. To recap, these hyper-parameters include
(i) α, the support level, and (ii) λ0, λ1, regularization
parameters for learning support rules. There are also
relevant hyperparameters in the underlying algorithm
of Wei et al. (2019), primarily the width of the beam
search used during column generation.
1This would be surprising, as men with arrhythmia are
fairly common in the general population
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Figure S1: Boolean rules on disjunctive normal form (DNF). We highlight data points represented by their
activations, a1·, a2· of rules from the set K of all possible rules. C is the region described by the rule set and r
indicators for the rules.
Summary: For this purpose, we recommend setting
α ≈ 1, and in particular we consistently observed best
results for α ≥ 0.98. We observe that for α sufficiently
close to 1, the results are less sensitive to different
values of λ0, λ1. In addition, we recommend setting
the width of the beam search in the algorithm of Wei
et al. (2019) to be on the same order of magnitude as
the number of binary features.
These recommendations have the effect of encourag-
ing the algorithm to consider higher-order interactions
between variables that describe regions with little or
no support in the data (e.g., “there are no men with
cardiac arrhythmia”), and we verify this through exper-
iments where we selectively remove regions of the data,
and verify whether or not the algorithm can recover
these regions.
Concretely, we use both a synthetic and semi-synthetic
case where we manually exclude all points which sat-
isfy a simple boolean rule, and look to identify that
exclusion automatically. That is to say, in both cases
we take a dataset and remove data points x ∈ {0, 1}d
which satisfy a rule of the form xi = 1 ∧ xj = 1 for
two features xi, xj , and then check if our algorithm
incorporates this into the learned rule set.
• Synthetic Case: In this setting, we generate data
comprised of 22 independent binary features, such
that 10 features are rare (binomial with p = 0.01),
12 features are common (p = 0.5), and we remove
all data points which satisfy a conjunction of the
last two common features.
• Semi-Synthetic Case (Antibiotic Prescrip-
tion): In this setting, we used the medical records
dataset described in Section 5.4, and removed all
men with cardiac arrhythmia, which compromised
5% of the total population.
This particular type of exclusion benefits from a CNF
formulation (AND of ORs) of the support task. This
is because the exclusion can be described in a parsimo-
nious way (independently of other aspects of support)
as a single additional rule. As discussed in Section 4.1,
it is straightforward to convert the CNF formulation to
a DNF formulation and vice versa. However, we note
that the CNF formulation (for a fixed number of refer-
ence samples) can be more computationally intensive
than the DNF formulation.
A.2.1 Synthetic Experiments
For the synthetic case, our goal is to build intuition
that we can validate in the semi-synthetic setting. We
will first describe our data-generating process in more
detail, and then describe the results and conclusions
from an exhaustive hyperparameter search.
Synthetic Data Generation: We generate data as
follows. Note that we are only concerned (for the
moment) with estimating support, so we do not include
any notion of treatment groups.
• We sample 10,000 data points x ∈ {0, 1}d where
d = 22, by sampling (for each data point):
– 10 “rare” binary features r1, . . . , r10, generated
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independently with p = 0.01
– 12 “common” binary features c1, . . . , c12, gen-
erated independently with p = 0.01
– Thus, each data point is given by x =
[r1, . . . , r10, c1, . . . , c12]
• We remove all data points which satisfy c11 =
1∧c12 = 1, which is approximately 25% of all data
points. Our goal is to recover the corresponding
inclusion rule as part of the final rule set of
c11 = 0 ∨ c12 = 0.
Hyperparameter Search & Outcomes: With this
setup, we estimate support using the algorithm given
in the main paper, using every combination of the
following hyperparameters
• α ∈ {0.95, 0.96, 0.97, 0.98, 0.99}, the constraint on
covering our data.
• λ0 ∈ {0, 10−6, 10−4, 10−2}, and λ1 ∈
{10−6, 10−4, 10−2}, the regularization terms.
• B ∈ {10, 15, 20, 25, 30}, the width of the beam
search used in Wei et al. (2019)
For each combination of hyperparameters, we run the
experiment three times, generating a new set of fake
data with each run. The same three random seeds
are used across all hyperparameter combinations. We
recorded a number of relevant outcomes, including
• Does the final rule set include the inclusion rule
c11 = 0 ∨ c12 = 0?
• How many rules are considered in the final rule
set, and how long (on average) are these rules?
• How many “perfect” rules are found, which exclude
none of the generated data points?
Observations: The full results of the hyperparameter
search are given in Table S5, but we summarize our
observations and recommendations here.
• Recovery by LP → recovery by rounded rules:
Across all hyperparameter settings, if the desired
inclusion rule was found during column generation
(and thus considered by the LP), it was uniformly
included in the final rounded rule.2 Thus, our goal
is to ensure that the desired inclusion is picked up
by the LP during column generation.
2This is not a general rule; While it holds in the synthetic
case, it will not hold exactly in the semi-synthetic case with
real data, as demonstrated in the next section.
• Beam Search Width should be higher than # fea-
tures: Recall that the LP relaxation with column
generation starts by considering only rules with
a single literal, and beam search is used to select
additional rules for consideration, with a maxi-
mum width of B. If B is lower than the number
of rare features, then the first B rules considered
will tend to be rules on single rare features. This
prevents the beam search from exploring interac-
tions between more prevalent features. Setting the
beam-search width to a sufficiently high number
(≈ total features) forces the column generation
to explore all rules with two literals, helpful for
recovery of our desired inclusion rule. This is
demonstrated in Table S1.
• Higher values of α produce more stable results
across λ. Higher values of α tends to render the
results less sensitive to choice of regularization λ,
and tends to produce more reliable results in terms
of recovery of our desired rule. As demonstrated in
Tables (S2a-S2c), lower values of α are more sensi-
tive to λ1 in terms of both recovering the desired
exclusion, as well as the number of rules found.
At higher values of α, there is more consistent
recovery of “perfect” rules, which exclude none of
the sample points (and hence do not contribute to
the constraint).
Table S1: Beam Search Width and proportion of runs
(across all other hyperparameter settings of α, λ0, λ1)
in which the synthetic region was correctly identified by
the final rule set (“Rounded”). Once the beam search
width is sufficiently high (larger than the number of
rare features), further increasing it does not appear to
help.
Beam Width 10 15 20 25 30
Recovered 0.07 0.87 0.87 0.87 0.87
Discussion / Intuition: Due to the greedy nature
of the column generation procedure, a common fail-
ure mode is to only consider rules that include rare
features, because those singleton rules exclude a signif-
icant amount of reference measure, and excluding rare
features does not violate the α-constraint. For instance,
a support rule of the form “not one of these K rare
features” will (roughly speaking) exclude K percent of
the samples (if each rare feature has 1% prevalence),
while producing a volume of 2−K . Thus, an overly
greedy approach can obtain an objective value that
is exponentially small in the number of rare features
excluded, as long as it does not hit the α constraint.
This has the effect of “crowding out” more complex
rules.
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(a) Recovery of inclusion rule
λ1 =1e-6 λ1 =1e-4 λ1 =1e-2
α = 0.95 1.0 1.0 0
α = 0.96 1.0 1.0 0
α = 0.97 1.0 1.0 1.0
α = 0.98 1.0 1.0 1.0
α = 0.99 1.0 1.0 1.0
(b) Avg. # of rules
λ1 =1e-6 λ1 =1e-4 λ1 =1e-2
α = 0.95 23.67 15.75 5.0
α = 0.96 35.58 33.33 4.0
α = 0.97 39.83 31.92 4.0
α = 0.98 44.17 47.17 23.83
α = 0.99 31.42 31.25 27.67
(c) Avg. # of Perfect Rules
λ1 =1e-6 λ1 =1e-4 λ1 =1e-2
α = 0.95 12.5 9.25 0.0
α = 0.96 20.75 18.67 0.0
α = 0.97 24.67 24.92 1.0
α = 0.98 30.17 28.33 14.0
α = 0.99 23.0 24.08 20.42
Table S2: Value of α parameter and λ1 parameters, for
a fixed beam search width (B = 15), along with (a)
the proportion of runs (across all other hyperparameter
settings) in which the synthetic region was correctly
identified by the final rule set, (b) the number of rules
in the final solution, and (c) the number of perfect rules,
defined as those which exclude none of the samples but
which exclude some number of reference points. Note
that these results marginalize over λ0, and (b-c) are
averaged across all runs.
Take a concrete example in Table S2b to build intuition
for how the greedy set covering algorithm can fail in
this case: Suppose λ0 = 0, λ1 = 0.01, and α = 0.95,
and suppose that our current solution excludes 5 rare
features before hitting the α constraint, then the ref-
erence volume is given by 2−5 ≈ 0.03. In this case,
adding the desired inclusion rule will reduce the vol-
ume by 1/4 (a reduction in absolute terms which is
< 0.01) while increasing the regularization penalty by
0.02. Thus, it will not be included.
To avoid this failure mode, we can increase α, which
has the effect of reducing the number of singleton rules
K that can be added before violating the constraint.
A.2.2 Semi-Synthetic Experiments
In the semi-synthetic experiment, our goal is to verify
that the intuition from the synthetic setting carries
over to a real dataset.
Semi-Synthetic Data Generation: We generated
the dataset for this experiment as follows.
1. Subsampling: We randomly sample 5000 patients
from the full cohort of 65k patients, due to com-
putational constraints. In this subset, there were
185 binary features, and 5 continuous features.
2. Synthetic Exclusion: We remove all male patients
with cardiac arrhythmia, which was around 5% of
the total population.
3. Pre-Processing: Given the prevalence of very rare
binary features, we removed all binary features
with a prevalence of less than 1%, as well as all
samples that had any of these features, resulting
in the removal of 118 binary features and 850
samples. This was done both for computational
reasons (to reduce the number of features) as well
as to condition the problem such that it is more re-
alistic for the support estimation to recover higher-
order interactions.
4. Final Dataframe: The final dataset had 66 binary
features and 5 continuous features, with the latter
being converted into binary features via the use of
deciles.
Hyperparameter Search: We then followed a simi-
lar approach to the synthetic experiment, using every
combination of the following hyperparameters. For
each combination, we ran the algorithm three times,
inducing randomness over the data by taking a random
80% of the data with each iteration.
• α ∈ {0.95, 0.96, 0.97, 0.98, 0.99}
• λ0 ∈ {10−6, 10−4, 10−2}, λ1 ∈ {10−6, 10−4, 10−2}
In this case, we fixed the width of the beam search at
B = 1000 (which encourages a more thorough search
during column generation, as discussed above), and
also found that we needed to adjust the value of K,
another hyperparameter from the column generation
algorithm, to be roughly on the same order as B. The
parameter K controls how many rules get added to
the LP at each iteration. We also fixed the maximum
number of iterations at 10. We recorded all the same
outcomes as were used in the synthetic case.
Observations: We observed that a number of pat-
terns from the synthetic case carried over to the semi-
synthetic case.
• Inclusion in LP (mostly) implies inclusion in final
rules: When the desired inclusion rule appears
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among the rules considered during column genera-
tion, it mostly appears in the final rounded rules,
in 80% of runs. We conjecture that this is due
to a large number of “perfect” rules existing in
this dataset, which are also two-variable interac-
tions, though many of these appear to be noise
(see example inclusion rules below).
• Increasing α leads to more consistent recovery in
the LP of the desired inclusion rule. However,
as discussed, this does not always translate into
the desired inclusion rule showing up in the final
rounded rule set. See Table S3
• Higher values of α are less sensitive to choice of λ:
In Tables (S4a-S4b) we demonstrate that, similar
to the synthetic case, the number of rules and
the number of “perfect” rules is highly sensitive
to λ1 when α is lower, but for α ≥ 0.98 it yields
consistent results across different values of λ.
Example “Perfect” Rules: These rules exclude none
of the samples in our data, while excluding reference
points. While occasional rules appear to be based
on reasonable exclusions (such as a lack of pregnant
veterans, given that 80% of veterans are male in our
data), most appear to be combinations of rare features
(such as rare medications) that simply do not appear
together in our data. These are three representative
rules from one run (where α = 0.99, λ0 = λ1 = 1e− 6,
resulting in 23 rules, of which 17 were “perfect”):
• not (Pregnant and Veteran)
• not (Complicated Hypertension and Previous Med-
ication of Cephalexin)
• not (Previous Medication of Doxycycline and Nor-
floxacin)
Table S3: Values of α and the proportion of runs in
which the desired inclusion rule was included in the
LP during column generation, as well as included in
the final rule set. Results are averaged over values of
λ0, λ1, with the exception of λ0 = λ1 = 1e− 2, because
this did not run for α = 0.97
LP Final Rule Set
α = 0.95 0.50 0.50
α = 0.96 0.75 0.71
α = 0.97 1.00 0.88
α = 0.98 1.00 0.62
α = 0.99 1.00 0.62
(a) Recovery of inclusion rule
λ1 =1e-6 λ1 =1e-4 λ1 =1e-2
α = 0.95 0.7 1.0 0.0
α = 0.96 1.0 0.8 0.0
α = 0.97 0.8 0.7 1.0
α = 0.98 0.7 0.5 0.7
α = 0.99 0.8 0.7 0.3
(b) Avg. # of rules
λ1 =1e-6 λ1 =1e-4 λ1 =1e-2
α = 0.95 210.2 115.8 6.0
α = 0.96 334.3 148.0 5.0
α = 0.97 25.2 75.2 49.8
α = 0.98 25.0 24.7 24.3
α = 0.99 23.3 23.3 23.7
(c) Avg. # of Perfect Rules
λ1 =1e-6 λ1 =1e-4 λ1 =1e-2
α = 0.95 200.2 105.8 0.0
α = 0.96 326.0 140.0 0.0
α = 0.97 19.5 69.0 42.2
α = 0.98 21.3 21.0 20.7
α = 0.99 19.0 18.7 19.7
Table S4: Value of α parameter and λ1 parameters,
along with (a) the proportion of runs (across all other
hyperparameter settings) in which the synthetic region
was correctly identified by the final rule set, (b) the
number of rules in the final solution, and (c) the number
of perfect rules, defined as those which exclude none
of the samples but which exclude some number of
reference points. Note that these results marginalize
over λ0 ∈ {1e − 6, 1e − 4} because λ0 = λ1 = 1e − 2
did not run for α = 0.97, and (b-c) are averaged across
all runs.
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Table S5: Rec: Proportion of runs where synthetic
exclusion was recovered. # R: Number of rules in
final output. # PR: Number of “perfect” rules which
exclude zero data points. Length: Average length of
rules. Each entry is the average of three independent
runs with different random seeds, and run with B = 15
α λ0 λ1 Rec # R # PR Length
0.95 0 1e-06 1.00 31.00 17.00 2.36
1e-04 1.00 19.33 12.00 2.25
1e-02 0.00 5.00 0.00 1.00
1e-06 1e-06 1.00 30.67 17.00 2.37
1e-04 1.00 19.33 12.00 2.25
1e-02 0.00 5.00 0.00 1.00
1e-04 1e-06 1.00 27.00 15.00 2.36
1e-04 1.00 18.33 12.00 2.23
1e-02 0.00 5.00 0.00 1.00
1e-02 1e-06 1.00 6.00 1.00 1.17
1e-04 1.00 6.00 1.00 1.17
1e-02 0.00 5.00 0.00 1.00
0.96 0 1e-06 1.00 46.33 28.33 2.69
1e-04 1.00 43.67 25.00 2.43
1e-02 0.00 4.00 0.00 1.00
1e-06 1e-06 1.00 45.33 27.67 2.70
1e-04 1.00 43.67 25.67 2.41
1e-02 0.00 4.00 0.00 1.00
1e-04 1e-06 1.00 45.67 26.00 2.67
1e-04 1.00 41.00 23.00 2.41
1e-02 0.00 4.00 0.00 1.00
1e-02 1e-06 1.00 5.00 1.00 1.20
1e-04 1.00 5.00 1.00 1.20
1e-02 0.00 4.00 0.00 1.00
0.97 0 1e-06 1.00 49.67 31.00 2.74
1e-04 1.00 38.00 30.00 2.51
1e-02 1.00 4.00 1.00 1.25
1e-06 1e-06 1.00 49.67 31.00 2.73
1e-04 1.00 38.00 30.00 2.51
1e-02 1.00 4.00 1.00 1.25
1e-04 1e-06 1.00 48.33 29.00 2.71
1e-04 1.00 37.33 29.33 2.55
1e-02 1.00 4.00 1.00 1.25
1e-02 1e-06 1.00 11.67 7.67 2.27
1e-04 1.00 14.33 10.33 2.43
1e-02 1.00 4.00 1.00 1.25
0.98 0 1e-06 1.00 47.00 33.67 2.82
1e-04 1.00 50.67 30.33 2.74
1e-02 1.00 27.33 16.00 1.97
1e-06 1e-06 1.00 46.67 33.33 2.81
1e-04 1.00 50.67 30.33 2.74
1e-02 1.00 27.00 15.67 1.97
1e-04 1e-06 1.00 46.00 31.33 2.74
1e-04 1.00 50.67 31.00 2.74
1e-02 1.00 28.00 16.33 1.99
1e-02 1e-06 1.00 37.00 22.33 2.29
1e-04 1.00 36.67 21.67 2.26
1e-02 1.00 13.00 8.00 1.95
0.99 0 1e-06 1.00 33.00 23.33 2.33
1e-04 1.00 33.00 27.33 2.33
1e-02 1.00 28.33 21.00 1.96
1e-06 1e-06 1.00 33.00 21.67 2.36
1e-04 1.00 34.33 24.67 2.30
1e-02 1.00 28.33 21.00 1.96
1e-04 1e-06 1.00 31.33 25.67 2.34
1e-04 1.00 27.00 20.67 2.17
1e-02 1.00 28.33 21.00 1.96
1e-02 1e-06 1.00 28.33 21.33 2.08
1e-04 1.00 30.67 23.67 2.11
1e-02 1.00 25.67 18.67 1.96
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B Application of OverRule to Policy
Evaluation
In this section we give the detailed algorithm for apply-
ing OverRule to policy evaluation, as described in the
main paper. In this context, we wish to evaluate not a
specific treatment decision (e.g., the average treatment
effect of giving a drug vs. withholding it), but rather
a conditional policy representing a personalized treat-
ment regime, which we will refer to as the target policy.
This problem falls under the setting of off-policy policy
evaluation when this target policy pi differs from the
policy which generated the data, which we observe in
the observational data as p(T = t | x).
Rationale for B(pi): In the main paper, we drew a
connection between the set B and the following set, a
function of the target policy pi, B(pi) := {x ∈ X ;∀t :
pi(t | x) > 0 : p(T = t | x) > }. In this section, we
recall the theoretical rationale for why we are restricted
to this set, if we wish to evaluate the policy pi given
samples generated according to p(T = t | x).
Following similar notation to Kallus and Zhou (2018),
we will letX ∈ X correspond to covariates, Y ∈ Y to an
outcome of interest, T ∈ T to a treatment decision. We
write pi(t|xi) as the probability of each treatment under
the policy, which may be stochastic. We write Y (t) to
represent the potential outcome under treatment t. In
this setting, we wish to evaluate the expected value of
Y under the target policy, which we denote as E[Y (pi)].
Proposition S1 (Informal). The expectation E[Y (pi)]
is only defined w.r.t. the observed distribution
p(X,T, Y ) for the subset B ∈ X such that ∀x ∈
B, pi(T = t | X = x) > 0 =⇒ p(T = t | X = x) > 0
Proof. Under the assumption that ignorability (Pearl,
2009) holds, we can write out our desired quantity as
follows in terms of observed distribution p(X,T, Y ).
For brevity, let p(t | x) = p(T = t | X = x), p(x) =
p(X = x), et cetera.
E[Y (pi)] (S1)
=
∫
X ,T ,Y
y · p(x)pi(t | x) · p(Y (t) = y | x, t)dxdtdy
=
∫
X ,T ,Y
y · p(x)pi(t | x)
p(t | x)
· p(Y (t) = y | x, t)p(t | x)dxdtdy (S2)
=
∫
X ,T ,Y
y · p(x)p(t | x)
· p(Y = y | x, t)pi(t | x)
p(t | x) dxdtdy (S3)
=
∫
X ,T ,Y
y · p(x, t, y) · pi(t | x)
p(t | x) dxdtdy (S4)
Where in Equation (S2) we multiply by one, in Equa-
tion (S3) we use the assumption of ignorability to write
p(Y (t) = y | X = x, T = t) = p(Y = y | X = x, T = t)
and rearrange terms, and in Equation (S4) we collect
the terms which represent the observed distribution.
For our purposes, it is sufficient to look at the inte-
gral in Equation (S4) to see that it requires the con-
dition that for all (x, t) ∈ X × T , the relationship
pi(T = t | X = x) > 0 =⇒ p(T = t | X = x) > 0 must
hold.
The condition given in Proposition S1 is sometimes
referred to as the condition of coverage (see Sutton
and Barto, 2017, Section 5.5) in off-policy evaluation.
Rewriting Equation (S4) as an expectation over the ob-
served distribution, we can see that this leads naturally
to the importance sampling (Kahn, 1955) estimator
E
[
Y
pi(T = t | X = x)
p(T = t | X = x)
]
≈ 1
n
n∑
i=1
yi
pi(ti | xi)
p(ti | xi) , (S5)
which approximates our desired quantity. If  >
p(t|x) > 0 for some small value of , then the vari-
ance of the importance sampling estimator increases
dramatically. This motivates our notion of “strict” cov-
erage, that for each value of x ∈ B(pi), we require that
for all actions t such that pi(t|x) > 0, the condition
p(t|x) >  must hold.
Note that this differs conceptually from the binary
treatment case in an important respect: Since we are
not seeking to contrast all treatments, we do not require
that µ(t|x) > , ∀t ∈ T , but rather just for those
treatments which have positive probability of being
taken under the target policy.
Algorithmic Details As described in the main pa-
per, applying OverRule to the policy evaluation setting
only requires a single change to the procedure, which
is that the set Bˆ(pi) is used in place of the set Bˆ in
Equation (9) in Section 4.2. Nonetheless, we provide
an explicit self-contained sketch of the procedure here
to avoid any confusion:
1. Given a dataset, find an α-MV set Sα using the
approach given in the main paper.
2. Using this set, learn the conditional probabilities
of each possible treatment t ∈ T , resulting in
estimated propensities pˆ(T = t | X = x)
3. For each data point in the support set Sα, assign
the label
bˆi(pi) =
∏
t∈pi(xi)
1[pˆ(T = t | X = xi) ≥ ],
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where pi(xi) := {t : pi(t|xi) > 0}. The set Bˆ(pi) is
the collection of data points such that bˆi(pi) = 1.
Note that we know the target policy pi that we
are evaluating, so we can evaluate pi(t|xi) for each
data point.
4. Solve the following Neyman-Pearson-like classifica-
tion problem, using the techniques discussed in the
main paper. Note that this is identical to solving
Equation (9) in Section 4.2, with the substitution
of Bˆ(pi) for Bˆ:
Bˆ(pi) := arg min
C
1
|Sˆ \ Bˆ|
∑
i∈Sˆ\Bˆ(pi)
1[xi ∈ C] +R(C)
s.t.
∑
i∈Sˆ∩Bˆ(pi)
1[xi ∈ C] ≥ β|Sˆ ∩ Bˆ(pi)| .
C Additional Experimental Results
As a general note across all experiments: When estimat-
ing support in OverRule, we use mR = c ·m ·d uniform
reference samples where c > 0 is some constant,m is the
number of data samples and d their dimension. Contin-
uous features were binarized by deciles unless otherwise
specified. Finally, for propensity-based base estimators,
we use the standard threshold  = 0.1 (Crump et al.,
2009) throughout.
C.1 Iris
For the results given in the paper, we fit OverRule using
a k-NN base estimator (k = 8) and DNF Boolean rules
for both support and overlap rules, with α = 0.9 and
regularization λ0 = 2 · 10−2, λ1 = 0 for support rules,
a cutoff of  = 0.1, and β = 0.9, λ0 = 10−2, λ1 = 0 for
overlap rules.
C.2 Jobs
For the results given in the main paper, we use the
following hyperparameters:
1. Support Rules: CNF formulation, along with
hyperparamters α = 0.98, λ0 = 10−2, λ1 = 10−3.
2. Base Estimators: For CBB we used α = 0.1,
for the logistic regression propensity estimator
we used C = 1 in LogisticRegression in scikit-
learn, and other hyperparameters were chosen
based on cross-validation: For k-NN, we selected
k ∈ {2, 4, . . . , 20} based on held-out accuracy in
predicting group membership and used 1/k as
threshold. For OSVM, we use a Gaussian RBF-
kernel with bandwidth γ ∈ [10−2, 102], selected
based on the held-out likelihood of kernel density
estimation.
3. Overlap Rules: We use a DNF formulation
with β = 0.9 and select λ0 ∈ [10−4, 10−1] and
λ1 ∈ [10−4, 10−2]. Within each class of base esti-
mators, we choose these parameters based on aver-
age training performance over 5-fold CV, choosing
the setting in each class that achieves a balanced
accuracy (with respect to the base-estimator over-
lap labels) within 1% of the best performing model
in the class, while minimizing the number of rules.
Note that the reported results are using the held-out
portions of each 5-fold CV run, and using the ground-
truth overlap labels, which are at no point used during
the hyperparameter tuning process. This reflects a
real-world scenario where ground-truth is unknown
and only the base-estimator derived labels are given.
The reported rules in the figure were selected from one
of the five cross-validation runs for the same hyperpa-
rameter setting chosen using the above procedure. In
Figure S2 we see the correlation between held-out bal-
anced accuracy for the rule set w.r.t. the experimental
label, and the balanced accuracy for the rule set in
approximating the base estimator. Note that AUC is
equal to balanced accuracy for binary predictions.
C.3 Opioids
For the results in the main paper, we fit an OverRule
model (OR) to a random forest base estimator with
β = 0.8 for B and α = 0.9 for S picked a priori. The
hyperparameter λ0 was set to λ0 =1e−3 for B, and
λ0 =1e−5 for S, and λ1 = 0 for both.
For a full table of covariate statistics for the Opioids
dataset, see Table S6. For a illustration of the rules
learned by OverRule to describe the complement of the
overlap set, see Figure S3.
Supplemental Rules: We learned an additional set
of rules, motivated by our experiments in Section 5.3,
where we noted that the support rules did not capture
certain combinations of surgery types or conditions
that should be rare or non-existent. This motivated the
empirical investigation in Section A.2, and this vignette
represents the result of re-running our procedure with
this goal in mind.
For support rules, we followed the recommendations
laid out in Section A.2, choosing to use a CNF for-
mulation with α = 0.98, λ0 = 0, λ1 = 0.01. Contin-
uous features were binarized using deciles. For our
base estimator, we used a random forest classifier with
100 trees and 20 minimum samples per leaf, and we
used  = 0.1 as our cutoff. For the overlap rules,
we searched over the following grid of hyperparame-
ters, with the goal of maximizing balanced accuracy
with respect to the overlap labels on a validation set:
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Figure S2: Results from the Jobs datasets for OverRule
approximations of different base estimators, sweeping
λ0, λ1. AUC (i.e., balanced accuracy) is measured with
respect to the experimental indicator. The dotted line
‘Propensity (base)’ refers to the logistic regression base
estimator, ‘k-NN (base)‘ refers to the k-NN base esti-
mator, and ‘SVM (base)‘ refers to the one-class SVM.
The colored points refer to performance of OverRule
using the respective base estimator, for different values
of λ0, λ1
β ∈ {0.8, 0.9, 0.95} and then a set where λ0 = 0 and
λ1 ∈ {10−3, 2 ·10−3, 10−2}, and a set where λ1 = 0 and
λ0 ∈ {10−3, 2 · 10−3, 10−2}. The selected hyperparam-
eters were β = 0.95, λ0 = 0, λ1 = 10−3. The support
rules cover 98.5% of the test samples, and the overlap
rules achieved a balanced accuracy of 0.96 on a held-out
test set (with respect to the overlap labels) and covered
36% of the test samples. The chosen ruleset is given in
given in Figures S4-S5.
We note that the resulting support rules, in line with the
findings in Section A.2, include a large number of rules
that exclude zero training data points, by identifying
rare interactions of features. For instance, the rules
identify that there are no men in our dataset who have
maternity surgery, an intuitive exclusion.
We shared this rule set with one of the participants of
the original user study, who made the following obser-
vations: First, the support rules in Figure S4 generally
made sense as excluding combinations that are intu-
itively absent from the data (e.g., men w/maternity
surgery) or that are just combinations of features that
are themselves rare. Regarding the overlap rules in
Figure S5, they observed that B.1 and B.2 were consis-
tent with clinical intuition, where B.2 likely serves to
exclude C-section patients with epidurals. B.3 and B.4
were intuitive with the exception of the negations, e.g.,
it is unclear what the role of abdominal pain is in B.3,
although it could be correlated with generalized pain
syndromes. B.5-B.7 correspond to individuals with
lower back pain (Lumbago) and neck pain (Cervicalgia)
which are intuitive indicates for higher doses of opioids.
B.8 corresponds to plastic surgery, and the broad cat-
egory of respiratory surgery in B.9 could correspond
to thoracic surgery, one of the main surgical categories
associated with opioid misuse. B.10-B.12 relate to back
pain, which is associated with higher opioid dosages.
C.4 Observational Study: Policy Evaluation
of Antibiotic Prescription Guidelines
Antibiotic resistance is a growing problem in the treat-
ment of urinary tract infections (UTI) (Sanchez et al.,
2016), a common infection for which more than 1.6
million prescriptions are given annually in the United
States (Shapiro et al., 2013). With this in mind, we
are interested in the following clinical problem: When
a patient presents with a UTI, the physician needs to
choose between a range of antibiotics, with the dual
goals of (a) treating the infection, and (b) minimizing
the use of broad-spectrum antibiotics, which are more
likely to select for drug-resistant strains of bacteria.
In this context, we might be interested in evaluating a
range of potential treatment policies. For our purposes,
we will use a pre-defined policy: The clinical guidelines
published by the Infectious Disease Society of America
(IDSA) for treatment of uncomplicated UTIs in female
patients (Gupta et al., 2011). Using the policy evalua-
tion formulation of B(pi), we will apply OverRule to
a conservative interpretation of the IDSA guidelines,
using data curated from the Electronic Medical Record
(EMR) of two academic medical centers.
The official guidelines discuss the importance of patient
and population level risk factors in predicting resistance,
and include some factors that we do not observe in our
data (such as drug allergies). In order to characterize
the guideline explicitly as a policy that we can evaluate
in our dataset, we used the following interpretation:
• Choose the first-line agent, either Nitrofurantoin
(NIT) or Trimethoprim/Sulfamethoxazole (SXT),
to which the patient did not have previous antibi-
otic exposure or resistance in the prior 90 days.
Additionally, if local rates of resistance to SXT
are ≥ 20% in the prior 30-90 days, then avoid
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History:¬ Injury of face and neck
and ¬ Unspecified septicemia 
and ¬ Other injury of chest wall 
and ¬ Acute respiratory failure
and ¬ Altered mental status 
and Surgical procedure:¬ Endocrine system
and ¬ Mediastinum (thoracic cavity)
and ¬Auditory system
Surgical procedure:¬ Respiratory
and ¬ Nervous
and ¬ Musculoskeletal
and ¬ Cardiovascular
and History:¬ Tobacco use disorder 
and ¬ Thoracic or lumbosacral 
neuritis or radiculitis: 
unspecified 
and ¬ Lumbosacral spondylosis 
without myelopathy 
and ¬ Degeneration of cervical 
intervertebral disc 
and ¬ Degeneration of lumbar or 
lumbosacral intervertebral disc
Surgical procedure:
Maternity
and History:
and ¬ Degeneration of lumbar or 
lumbosacral intervertebral disc 
Rule S.1: Rule B.1: or Rule B.2:
𝒪# = S.1 ∧ ¬ (B.1 ∨ B.2)
Support rules 𝒮( Propensity overlap complement rules ℬ*+
Figure S3: OverRule description of the complement of the overlap between post-surgical patients with higher and
lower opioid prescriptions. If the support rule (left) applies and neither propensity overlap rule (right) applies, a
patient is consider to be in the overlap set. ¬ indicates a negation. The rules cover 36% of patients with balanced
accuracy 0.92 w.r.t. the base estimator (random forest). Procedures are not mutually exclusive.
prescription of SXT.
• If neither of the first-line agents are indicated, then
prescribe Ciprofloxacin (CIP), a second-line agent.
Experimental details From our data set, we se-
lected all patients from 2007–2017 which had a UTI,
and were prescribed one of the four most common
antibiotics: NIT, SXT, CIP, or Levofloxacin (LVX).
Features include demographics (race, gender, age, and
veteran status), comorbidities observed in the past 90
days, information about previous infections (organism,
antibiotics given, and resistance profile), hospital ward
(inpatient, outpatient, ER, and ICU), and indicators
for pregnancy and nursing home residence in the past
90 days. The local rates of resistance (for each hospital
ward) are given over the past 30–90 days, and used at
the patient level as a feature, as well as an input to the
decision of the guidelines.
We preprocess our data first, removing any binary
feature with a prevalence of less than 0.1%, and any
associated subject: This results in the removal of 48
binary features with less than 0.1% prevalence and
888 corresponding subjects. This leaves a total of 156
(150 binary, 6 continuous) features and 64593 subjects.
Detail on all remaining features are given in Table S7.
For the purposes of running our algorithm, we convert
all continuous variables into binary variables by using
indicator functions for deciles.
We then characterize the support set Sα as described
in the main paper, using a DNF formulation, along
with α = 0.95, λ0 = 0.01, λ1 = 0. Using the data points
which fall into the support set, we then estimate the
propensity p(t|x) of prescribing each of the four drugs
using a random forest classifier, with hyperparameter
selection done using 5-fold cross-validation on 80%
of the remaining cohort used as a training set, over
the following parameter grid: Number of estimators
∈ [100, 500], Minimum samples per leaf (as fraction of
total) ∈ [0.005, 0.01, 0.02]. The resulting calibration
curves for each antibiotic are given in Figure S6, using
the remaining held-out 20% of the data. Using these
propensity scores, we apply the procedure described
in Section B to estimate the region of strict coverage,
Bˆ(pi) using Boolean rules, and the resulting rules are
given in Figure S7. For this stage, we used a DNF
formulation and hyperparameters of β = 0.9, λ0 =
0.03, λ1 = 0.
Clinical Validity / Interpretation Towards un-
derstanding the clinical validity of these rules, we inter-
viewed a clinician who specialises in infectious diseases.
First, we asked them, based on the available features,
which they would expect to differentiate between sub-
jects for whom the policy is or is not followed. They
noted that the guidelines are designed for uncompli-
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NONE OF: 
Support rules ෡𝓢
Male
and Proc: Maternity
Proc: Auditory
Hist: Unspecified septicemia
Hist: Acute respiratory failure
Male
and Proc: Female Genital
Hist: Other screening mammogram
and Proc: Male Genital
Proc: Musculoskeletal
and Proc: Male Genital
Hist: ADD (w/hyperactivity)
and (Hist: Rheumatoid arthritis
OR Hist: Other symptoms referable to back
OR Hist: Myalgia and myositis: unspecified)
Hist: ADD (without hyperactivity)
and (Hist: Rheumatoid arthritis
OR Hist: Other symptoms referable to back
OR Proc: Male Genital)
Hist: Major depressive affective disorder
and (Hist: Other symptoms referable to back
OR Proc: Male Genital)
Proc: Respiratory
and Proc: Female Genital
Hist: Injury of face and neck
and Proc: Male Genital
Hist: Hypopotassemia
and Hist: Hypersomnia with sleep apnea
Hist: Injury of face and neck
and Proc: Fitting and adjust. of vascular catheter
Figure S4: Support Rules using CNF formulation for the Opioids task. Proc indicates a procedure, and Hist
indicates a history of a condition. A sample is considered in the support set if NONE of the above rules apply.
Note that rules are negated for simplicity of presentation, as “AND NOT (X AND Y)” is equivalent to “AND
(NOT X OR NOT Y)”, and in some cases several rules are combined for simplicity of presentation (e.g., those
related to Attention Deficit Disorder). Dark green rules are highlighted to indicate that they cover <4 training
samples (and in many cases zero training samples) in line with our findings in Section A.2 for this setting of
hyperparameters.
cated cases: In particular, patients who have a Foley
catheter (a catheter used to drain urine from the blad-
der) are not covered under these guidelines, because
infections in these patients tend to be more complex
(e.g., the infection could have been introduced by the
catheter itself). The use of the Foley catheter is com-
mon during intensive care (e.g., in the ICU), so complex
hospitalized patients are less likely to be treated ac-
cording to the guidelines.
With that in mind, they reviewed the available features
and noted the following: (i) While UTIs are common
for women, they are rare for men; Men with UTIs
tend to be more complicated cases, because it is in-
dicative of deeper abnormalities. Similarly, pregnant
women are excluded from the guidelines. (ii) Of the
comorbidities given, none of them should directly dis-
qualify patients from the guidelines, except potentially
for complicated diabetes. (iii) Prior organisms / re-
sistance / prescriptions should not directly disqualify
patients from the guidelines, though they will influence
the type of antibiotic given. In particular, if a patient
has had previous resistance to an antibiotic, they are
unlikely to be prescribed it again. (iv) The previous
procedures given (with the exception of surgery) are
associated with ICU patients. For instance, mechanical
ventilation and parenteral nutrition are exclusive to the
ICU, and those patients likely have a Foley catheter
as well. Surgery is too broad of a category to draw
any conclusions. (v) In terms of locations besides the
ICU, patients who are admitted to the hospital and
who are on intravenous (IV) antibiotics already will be
treated differently. The guidelines are focused on oral
antibiotics, whereas if an IV already exists, additional
IV antibiotics are likely to be given instead.
Having discussed these points first, we then showed
them the rules learned by the OverRule algorithm,
and asked for their interpretation, as well as for any
critiques of the rules based on their clinical knowledge.
Their reaction to each of the rules was as follows:
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Proc: Musculoskeletal
Rule B.1 (19.0%)
Overlap rules ෡𝓑
Proc: Nervous
and ¬ Proc: Maternity
OR Rule B.2 (11.6%)
Male
and Age ≥ 51 years
and ¬ Hist: Abdominal pain: unspecified site
and ¬ Proc: Male Genital
OR Rule B.3 (10.4%)
Male
and Proc: Cardiovascular
and ¬ Proc: Male Genital
OR Rule B.4 (5.4%)
Male
and Hist: Lumbago
OR Rule B.5 (4.0%)
Age ≥ 44 years
and Hist: Lumbago
OR Rule B.6 (6.7%)
Age ≥ 44 years
and Hist: Cervicalgia
OR Rule B.7 (4.1%)
Age ≥ 44 years
and Proc: Integumentary
OR Rule B.8 (2.1%)
Age ≥ 38 years
and Proc: Respiratory
OR Rule B.9 (1.4%)
Hist: Thoracic or lumbosacral neuritis or radiculitis
and ¬ Proc: Maternity
OR Rule B.10 (4.1%)
Hist: Degeneration of cervical intervertebral disc
and ¬ Proc: Maternity
OR Rule B.11 (4.1%)
Hist: Lumbosacral spondylosis w/o myelopathy
OR Rule B.12 (3.3%)
Figure S5: Overlap rules, where the percentage next to each rule indicates the percentage of the dataset that is
covered by that rule. Collectively, these rules cover 36% of the held-out datapoints.
• Rule B.1: This appears to correspond to a rel-
atively straightforward young inpatient female
(given that Rule B.2 covers all outpatient females).
In particular, it rules out ICU patients directly, as
well as those with recent mechanical ventilation,
which would indicate a recent ICU stay. It also
rules out patients with current bloodstream infec-
tions, and those who had previously been tested for
(and found to be) resistance to Streptomycin (syn-
ergistic): This is only tested for in the context of
bloodstream infections by enterococcus, and would
be an indicator of previous bloodstream infections.
Imipenem is an IV antibiotic only given in inpa-
tient settings, and posaconazole is an antifungal
used in bone marrow transplant patients. Patients
who are both young and in a nursing home tend
to be more complex, e.g., they may be paralysed
or otherwise unable to perform activities indepen-
dently. Finally, the excluded comorbidities are less
intuitive, because some of them (e.g., congestive
heart failure) manifest with a range of severity:
For patients with controlled congestive heart fail-
ure, this is not a contraindication for following the
guidelines, but if they are fully decompensated,
then they would likely be on a Foley catheter.
• Rule B.2: This concisely describes the most com-
mon manifestation of UTI and the set of patients
who are most likely to be treated according to the
guidelines3.
• Rule B.3: The conjecture is that this represents
patients who have had an uncomplicated UTI in
the past, since patients are usually tested for the
antibiotics under consideration by a physician, and
since nitrofurantoin is one of the first-line treat-
ments for uncomplicated UTIs.
From a quantitative perspective, we compared the
learned region with an explicitly constructed cohort
of patients whose inclusion criteria were explicitly de-
signed to make them eligible for application of the
IDSA guidelines. In particular, we defined this cohort
as including non-pregnant women between the ages
of 18 to 55 years of age with no record of genitouri-
nary surgery or instrumentation, immunosuppression,
indwelling catheters, or neurologic dysfunction in the
3Note that outpatient and “not inpatient” can appear in
the same rule without being redundant, because multiple
specimens collected on the same day for the same patient
are collapsed into a single subject.
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Trimethoprim/Sulfamethoxazole (SXT)
Perfectly calibrated
Cutoff
Pred. (Brier Score: 0.18)
Figure S6: Calibration curves for each antibiotic, using
20 evenly spaced bins in the range [0, 1]. Numbers
indicate the number of samples, and are given when
when the number of samples in a bin is less than 0.5%
of the total. The cutoff is a reminder that  = 0.1
in this experiment: For any subject with covariates
x, the propensity must be above this cutoff for every
treatment under the target policy (i.e., for all t such
that pi(t|x) > 0) for them to be included in the coverage
region.
preceding 90 days. There were 14k of these patients,
21% of the total.
In relationship to this conservative subset, the learned
region (covering 42k patients, 64% of total) covers
96% of the explicitly constructed cohort, while also
demonstrating that a broader set of patients are treated
according to these guidelines in practice.
D Theoretical Results on Regularized
Minimum-Volume Boolean Rules
D.1 Bounds on minimum volume
In this subsection, we derive lower bounds on the vol-
ume of optimal DNF Boolean rules in problem (5).
First we obtain an expression for the normalized volume
of a clause in a DNF (we use the terms clause and
conjunction interchangeably in the case of a DNF).
We express the domain X as the Cartesian product
X1×· · ·×Xd. A DNF rule with K clauses ak is written
as
r(x) =
K∨
k=1
ak(x) =
K∨
k=1
∧
j∈Jk
(xj ∈ Sjk) , (S6)
where Jk is the set of covariates participating in clause
k, and each xj ∈ Sjk ⊆ Xj is a subset membership
condition on an individual covariate. Examples of
such conditions are (Age ≥ 30) for a continuous-valued
covariate and (Sex = Female) for a discrete-valued one.
For j /∈ Jk, it is understood that xj ∈ Xj , i.e. there is
no restriction on xj . The volume of clause ak is then
given by the product
V (ak) =
∏
j∈Jk
|Sjk|
∏
j /∈Jk
|Xj |,
where |Sjk| is the length of subset Sjk for a continu-
ous covariate j or the cardinality of Sjk for a discrete
covariate, and similarly for |Xj |. Likewise, the volume
of X is ∏dj=1|Xj |, and the normalized volume of ak is
therefore
V¯ (ak) =
∏
j∈Jk
fjk, fjk =
|Sjk|
|Xj | ∈ [0, 1]. (S7)
We define pk = |Jk| to be the degree of conjunction k.
Proposition S2. Assume that the regularization R(r)
follows (6). Then in any optimal solution to (5), all
clauses ak of degree pk have normalized volume satisfy-
ing V¯ (ak)(pk−1)/pk − V¯ (ak) ≥ λ1.
Proof. Suppose that rule r with corresponding set C
is an optimal solution to (5). Recalling the expan-
sion in (S6), we consider modifications to r in which
one condition (xj ∈ Sjk) is removed from a clause
ak. The modified rule satisfies the mass constraint
P (C) ≥ α because it covers at least those points cov-
ered by r. From (S7), the increase in volume is at
most V¯ (ak)((1/fjk)− 1), with equality if none of the
additional volume is already covered by another clause
in r, while the complexity penalty decreases by λ1. The
change in objective value is thus bounded from above
by
V¯ (ak)
(
1
fjk
− 1
)
− λ1.
This upper bound must be non-negative as otherwise r
is not optimal. In particular, for fjk = maxj′∈Jk fj′k
and all k we have
V¯ (ak)
(
1
maxj∈Jk fjk
− 1
)
≥ λ1.
Since (S7) implies that maxj∈Jk fjk ≥ V¯ (ak)1/pk , the
desired result follows.
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Rule S.1 (99.0%):
Previous Resistance:
¬Amikacin
and ¬ Ertapenem
and ¬ Linezolid
and ¬ Meropenem
and ¬ Nalidixic Acid
and Previous Prescription:
¬Amikacin
and ¬ Daptomycin
and ¬ Tetracycline Metronidazole
and ¬ Trimethoprim
and Previous Infections:
¬ Morganella
or Rule B.3 (3.6%):
Previous Resistance:
Nitrofurantoin
or Rule B.2 (58.4%):
Female
and Location of care:
Outpatient
and ¬ Inpatient
Rule B.1 (27.3%):
Age < 41 years 
and Female
and Location of care
¬ Intensive Care Unit (ICU)
and Secondary infection sites
¬ Bloodstream
and Medical History:
¬ Congestive Heart Failure
and ¬ Fluid/Electrolyte Disorders
and ¬ Metastatic Cancer
and ¬ Pulmonary Circ. Disorders
and Previous Prescription:
¬ Imipenem
and ¬ Posaconazole
and Previous Resistance:
¬ Streptomycin (synergistic)
and Previous Medical Care:
¬ Mechanical Ventilation
and ¬ Nursing Home
෠𝒪 = S.1 ∧ (B.1 ∨ B.2 ∨ B.3)
Support rules ෡𝓢 Propensity overlap rules ෡𝓑
Figure S7: OverRule description of the coverage region for policy evaluation of the clinical guidelines. Beside each
rule we give the percentage of subjects that are covered by the rule in the test set. Overall, the rules for Bˆ cover
65.4% of the data points in the support region (compared to the 71% of points labelled by our base estimator),
and they have an balanced accuracy of 0.96 versus the base estimator.
For p > 1, the function V¯ (p−1)/p − V¯ is positive and
concave on (0, 1) with roots at 0 and 1. For λ1 > 0,
the equation V¯ (p−1)/p − V¯ = λ1 therefore has either
two roots, 0 < V¯L < V¯U < 1, which define an interval
where the inequality V¯ (p−1)/p − V¯ ≥ λ1 is satisfied, or
no roots if λ1 is too large. We are interested primarily
in the root V¯L as a lower bound on volume. While V¯L
is not available in closed form for p > 2, the following
corollary gives a simple expression that is a lower bound
on V¯L.
Corollary S1. Under the assumption in Proposi-
tion S2, in any optimal solution to (5), all clauses
ak of degree pk > 1 have normalized volumes of at least
λ
pk/(pk−1)
1 .
Proof. Proposition S2 implies V¯ (ak)(pk−1)/pk ≥ λ1 af-
ter dropping −V¯ (ak) from the left-hand side.
Lastly, since the volume of a DNF rule is at least that
of any of its clauses, we have the following.
Corollary S2. Under the assumption in Proposi-
tion S2, any optimal solution to (5) has normalized vol-
ume of at least λpmax/(pmax−1)1 , where pmax = maxk pk
is the largest degree of its clauses.
D.2 Bounds on the number of candidate
DNF rules
The results in the previous subsection are necessary
conditions of optimality for problem (5). The implica-
tion is that in searching for optimal solutions to (5),
we may restrict the class C of DNF rules considered
to those satisfying these necessary conditions. In this
subsection, we develop the consequences of this restric-
tion, culminating in a bound on |C|, the number of
candidate DNF rules (Lemma S5).
For simplicity, we assume in the following that all
variables Xj are binary-valued. An extension to non-
binary categorical variables and continuous variables
(discretized using interval conditions lj ≤ xj ≤ uj)
is likely possible with the additional complications of
accounting for the cardinalities of categorical variables
and bounding the fractions fjk associated with contin-
uous variables.
Characterization of Overlap in Observational Studies
First, the simplified lower bound on volume in Corol-
lary S1 implies an upper bound on conjunction degree.
Lemma S1. Assume that the regularization R(r) fol-
lows (6) and that all variables are binary. Then in
any optimal solution to (5), the maximum degree of a
conjunction is pmax := 1 + blog2(1/λ1)c.
Proof. The normalized volume of a conjunction of de-
gree pk is 2−pk . Corollary S1 then requires
2−pk ≥ λpk/(pk−1)1 .
Taking logarithms and rearranging, we obtain
−1 ≥ 1
pk − 1 log2 λ1,
pk ≤ 1 + log2(1/λ1).
The right-hand side can be rounded down since pk is
integer.
Given Lemma S1, we may enumerate DNF rules satis-
fying the lemma according to the numbers of clauses
of degree p = 1, . . . , pmax that they possess. Denote
by Kp the number of clauses of degree p and call
K = (K1, . . . ,Kpmax) the signature of a DNF rule.
The signatures of optimal DNF rules obey the follow-
ing constraint.
Lemma S2. Under the assumptions of Lemma S1, the
signature K = (K1, . . . ,Kpmax) of an optimal solution
to (5) must satisfy
pmax∑
p=1
Kp(λ0 + pλ1) < 1. (S8)
Proof. From (6), the complexity penalty of a solution
with Kp clauses of degree p, p = 1, . . . , pmax is given by
the left-hand side of (S8). For a solution to be optimal,
it must have lower cost than the trivial “all true” rule,
which has a normalized volume of 1 and complexity
penalty of 0. In particular, the complexity penalty
must be less than 1.
Let ∆ denote the set of signatures that satisfy (S8),
and for K ∈ ∆, let C(K) be the set of DNF rules with
signature K. The number of DNF rules satisfying the
necessary conditions of optimality in Lemmas S1 and
S2 can be bounded as follows:
|C| =
∑
K∈∆
|C(K)| ≤ |∆|max
K∈∆
|C(K)|. (S9)
The next two lemmas provide upper bounds on the two
right-hand side factors in (S9).
Lemma S3. The number of signatures satisfying (S8)
is bounded as
|∆| ≤ 2
(
1
λ1
)pmax
.
Proof. For simplicity, we consider a superset ∆0 ⊇ ∆
obtained by dropping λ0 from (S8), i.e.
pmax∑
p=1
pλ1Kp ≤ 1. (S10)
Condition (S10) together with the implicit non-
negativity constraints Kp ≥ 0, p = 1, . . . , pmax define
a simplex in pmax dimensions. Bounding the number
of signatures in ∆0 is thus equivalent to bounding
the number of non-negative integer points in this sim-
plex. This problem has been studied extensively by
mathematicians. Applying e.g. (Yau and Zhang, 2006,
eq. (1.5)), we have
|∆0| ≤ 1
pmax!
pmax∏
p=1
1
pλ1
(
1 +
pmax∑
p=1
pλ1
)pmax
=
1(
pmax!
)2 ( 1λ1
)pmax (
1 +
pmax(pmax + 1)λ1
2
)pmax
≤
(
1
λ1
)pmax (1 + pmax(pmax + 1)2−pmax)pmax(
pmax!
)2︸ ︷︷ ︸
F (pmax)
,
where the last inequality is obtained by using the defi-
nition of pmax in Lemma S1 to bound λ1/2 ≤ 2−pmax .
To complete the proof, we bound the function F (pmax)
from above. The numerator of F (pmax) converges to
1 as pmax → ∞, as seen by taking its logarithm and
bounding it:
pmax log
(
1 + pmax(pmax + 1)2
−pmax)
≤ p2max(pmax + 1)2−pmax → 0 as pmax →∞.
Thus F (pmax) decreases to zero as pmax increases. Nu-
merical evaluation shows that F (pmax) attains a maxi-
mum value of 2 at pmax = 1.
Lemma S4. The maximum number of DNF rules with
a given signature K ∈ ∆ is bounded as
max
K∈∆
|C(K)| < (2d)1/λ1 .
Proof. The number of conjunctions of degree p is
(
d
p
)
2p,
where the factor of 2p is due to there being two choices
of conditions on each of the p selected variables. The
number of DNF rules with signature K is therefore
|C(K)| =
pmax∏
p=1
((d
p
)
2p
Kp
)
<
pmax∏
p=1
((
d
p
)
2p
)Kp
Kp!
.
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Taking logarithms, we obtain
max
K∈∆
log|C(K)| <
max
K
pmax∑
p=1
Kp log
((
d
p
)
2p
)
− log(Kp!)
s.t.
pmax∑
p=1
Kp(λ0 + pλ1) ≤ 1. (S11)
For simplicity, we drop the nonlinear term − log(Kp!) ≤
0. The right-hand side of (S11) then becomes a max-
imization of a linear function over a simplex. The
maximum value is given by
max
p=1,...,pmax
log
((
d
p
)
2p
)
λ0 + pλ1
(S12)
(attained by setting Kp∗ = 1/(λ0 + p∗λ1) for a max-
imizing value p∗ and Kp = 0 otherwise). Again for
simplicity, we further bound (S12) from above by drop-
ping λ0 from the denominator, resulting in
max
K∈∆
log|C(K)| < 1
λ1
max
p=1,...,pmax
1
p
log
(
d
p
)
+ log 2
(otherwise (S12) may require solving a transcendental
equation). Since log
(
d
p
)
increases sublinearly with p,
the maximum occurs at p = 1, yielding the desired
result.
By combining (S9), Lemmas S3 and S4, we obtain the
desired bound on the number of DNF rules satisfying
the optimality conditions in Lemmas S1 and S2.
Lemma S5. Under the assumptions of Lemma S1, the
number of DNF rules satisfying the necessary conditions
of optimality in Lemmas S1 and S2 is bounded as
|C| < 2(2d)1/λ1
(
1
λ1
)pmax
.
D.3 Proof of Theorem 1
We prove the theorem in two steps, first relating the
empirical estimator in (7) to a problem intermediate
between (5) and (7),
S∗ := arg min
C
Q(C) := V¯ (C) +R(C)
subject to
∑
i∈I
1[xi ∈ C] ≥ αm, (S13)
and then relating this intermediate problem (S13) to
(5). Problem (S13) has the same regularized volume
objective as (5) but with the empirical probability
constraint of (7).
For the first step, let Vˆ (C) denote the empirical volume
in (7) (i.e. the first term in the objective function). As
noted in Section 4.1, Vˆ (C) is a scaled binomial random
variable with n trials and mean V¯ (C). Hoeffding’s
inequality thus provides the following tail bound:
Pr
(∣∣Vˆ (C)− V¯ (C)∣∣ > n) ≤ 2e−2n2n .
Defining Qˆ(C) = Vˆ (C) + R(C) and recalling that
Q(C) = V¯ (C) + R(C), the same bound holds for the
difference Qˆ(C)−Q(C). Taking the union bound over
the hypothesis class C yields
Pr
(∃C ∈ C : ∣∣Qˆ(C)−Q(C)∣∣ > n) ≤ 2|C|e−2n2n . (S14)
Assuming that the event in (S14) is not true, we obtain
the following sequence of bounds, where the second
inequality is due to the optimality of Sˆ in (7):
Q(Sˆ) ≤ Qˆ(Sˆ) + n ≤ Qˆ(S∗) + n ≤ Q(S∗) + 2n.
(S15)
For this to hold with probability at least 1− δ, we set
δ equal to the right-hand side of (S14) to obtain
n =
√
log(2|C|/δ)
2n
. (S16)
For the second step, we observe that the empirical
probability Pˆ (C) = 1m
∑
i∈I 1[xi ∈ C] is also a scaled
binomial random variable, this time with m trials and
mean P (C). We thus have a similar bound as in (S14),
Pr
(∃C ∈ C : ∣∣Pˆ (C)− P (C)∣∣ > m) ≤ 2|C|e−2m2m ,
and setting the right-hand side equal to δ yields the
same expression for m as in (S16) with n replaced by
m. We then use Theorem 3 and Corollary 12 in (Scott
and Nowak, 2006) to conclude that with probability at
least 1− δ,
Q(S∗) ≤ q∗(α+ m) and P (S∗) ≥ α− m.
Indeed, since Sˆ ∈ C and satisfies the constraint Pˆ (Sˆ) ≥
α as well, the above may be changed to
Q(S∗) ≤ q∗(α+ m) and P (Sˆ) ≥ α− m. (S17)
Combining (S15) and (S17) gives
Q(Sˆ) ≤ q∗(α+ m) + 2n and P (Sˆ) ≥ α− m
with probability at least 1− 2δ.
Lastly, we use Lemma S5 to bound n from above by√
λ−11 log(2d) + pmax log λ
−1
1 + log(4/δ)
2n
and similarly for m.
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E Generalization of the product
estimator
Below, we give a Theorem bounding the expected error
of the two-stage estimate Oˆ = Sˆ ∩ Bˆ as a function of
the error of the base estimators Sˆ, B˜. This justifies
the two-stage nature of our algorithm and motivates
selecting hyperparameters for overlap rules Bˆ based on
the error with respect to the base estimator B˜. Before
we state the result, we give a Lemma bounding the
error of an estimator of a product of functions in terms
of estimators of the respective terms in the product.
Consider the task of predicting the binary determin-
istic label g(X) = g1(X)g2(X) by approximating the
product of estimators f1, f2 of g1, g2. Now, let Rg(f)
denote the expected zero-one loss of f with respect to
g over p,
Rg(f) = E
X∼p
[1[f(x) 6= g(x)]] .
Lemma S6. For f1 and f2 such that Rg1(f1) ≤
A ≤ min{p(f2(X) = 1), p(g2(X) = 1)}, Rg2(f2) ≤
B ≤ min{p(f1(X) = 1), p(g1(X) = 1)} and max{A +
B,C} ≤ 1/2, let f(X) approximate f1(X)f2(X) and
assume that Rf1f2(f) ≤ C. Then,
Rg(f) ≤ A+B + C
Proof. For convenience, let f1 = f1(X), g1 = g1(X), et
cetera, and let γ = p(g(X) = 1).
Rg(f1f2) = p(f1f2 6= g1g2)
= p(f1 = f2 = 1 ∧ (g1 = 0 ∨ g2 = 0))
+ p((f1 = 0 ∨ f2 = 0) ∧ g1 = g2 = 1)
≤ p(f1 = f2 = 1 ∧ g1 = 0) + p(f1 = f2 = 1 ∧ g2 = 0)
+ p(g1 = g2 = 1 ∧ f1 = 0) + p(g1 = g2 = 1 ∧ f2 = 0)
≤ min{p(h2 = 1), p(f1 = 1 ∧ g1 = 0)}
+ min{p(f1 = 1), p(f2 = 1 ∧ g2 = 0)}
+ min{p(g2 = 1), p(g1 = 1 ∧ f1 = 0)}
+ min{p(g1 = 1), p(g2 = 1 ∧ f2 = 0)}
≤ A+B
In the first inequality, we use the standard Frechet
inequalities. In the second and third, we use the as-
sumptions in the statement. Alternatively, we could
arrive at the same result by assuming that h2 and
(f1, h1) as well as h1 and (f2, h2) are independent and
decomposing the joint distributions. This could be
guaranteed by sample splitting. We could then remove
the assumption that the marginal probability of the
label is larger than the error. In either case,
Rg(f) = p(f = f1f2 ∧ f1f2 6= g)
+ p(f 6= f1f2 ∧ f1f2 = g)
≤ min{p(f = f1f2), p(f1f2 6= g)}
+ min{p(f 6= f1f2), p(f1f2 = g)}
= p(f1f2 6= g) + p(f 6= f1f2)
≤ A+B + C .
We now state our result. First, we view membership in
Oˆ = Sˆ∩Bˆ as given by an instance of the hypothesis class
F = {f(x) := 1[x ∈ Sˆ]h(x);h ∈ H}, for some function
family H. Then, let Rg(f) = EX∼p[1[f(x) 6= g(x)]]
denote the expected risk of f with respect to g over
p, and Rˆg(f) = 1m
∑m
i=1 1[f(xi) 6= g(xi)] the empirical
risk.
Theorem S2. Given are classifiers sˆ, b˜ of support
membership s and propensity boundedness b, with over-
lap defined as o(x) = s(x)b(x), such that for all n > N
it holds for An, Cn ∈ O˜(1/
√
n) with max{An, Cn} ≤
1/4 that Rs(sˆ) ≤ An, Rb(b˜) ≤ Cn. Then, for any func-
tion oˆ ∈ H approximating sˆ · b˜, with probability larger
than 1− δ,
Ro(oˆ) ≤ Rˆsˆ·b˜(oˆ) +
DF,δ,n√
n
+ O˜
(
1√
n
)
,
where DF,δ,n =
√
8d(log 2md + 1) + 8 log
4
δ , with d the
VC-dimension of F and O˜ hides logarithmic factors.
Proof. From Lemma S6 and assumptions, we have that
Ro(oˆ) ≤ Rsˆ·b˜(oˆ)+Rs(sˆ)+Rb(b˜) ≤ Rsˆ·b˜(oˆ)+O˜
(
1√
n
)
.
By applying standard VC-theory w.r.t. F , we have our
result.
Theorem S2 bounds the generalization error of (e.g.,
Boolean rule) approximations of
√
n-consistent base
estimators. It may be generalized to other rates, but
convergence at some rate is necessary for consistency
of the final estimator. Critically, the bias incurred by
the approximation is observable and may be traded off
for interpretability.
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Table S6: Population averages for covariates in Opioids in order of difference between the overlapping and
non-overlapping set. DMME, MME and Duration are the medians of daily MME, total MME and prescription
duration days in each group.
Total DMME MME Duration
Total sample 35106 46 225 5
Male 9301 50 300 5
Female 25805 45 225 5
Age groups
<15 847 20 100 5
15-24 3334 45 200 5
25-34 9994 45 210 4
35-44 6820 46 225 5
45-54 6196 50 250 5
55-64 7915 50 300 5
>=65 0 0 0 0
Surgery type
Auditory 29 18 135 6
Cardiovascular 3633 45 270 5
Integumentary 1507 48 225 5
Mediastinum 54 47 300 5
Female genital 3913 48 225 5
Hemic 885 50 225 5
Respiratory 665 45 250 5
Endocrine 214 45 200 5
Nervous 4350 60 375 6
Urinary 1476 45 225 5
Musculoskeletal 6678 60 450 7
Maternity 13553 45 200 4
Male genital 585 45 225 5
Year
2011 7547 45 225 5
2012 10743 46 225 5
2013 9651 50 225 5
2014 7165 45 225 5
Diagnosis history (until day before surgery)
Other specified gastritis: without mention of hemorrhage 491 42 225 5
Other ascites 233 45 225 5
Lumbosacral spondylosis without myelopathy 1135 60 400 6
Nausea with vomiting 1914 45 225 5
Other respiratory abnormalities 1935 45 225 5
Vomiting alone 765 45 200 5
Myalgia and myositis: unspecified 1522 50 250 5
Attention deficit disorder with hyperactivity 370 45 225 5
Attention deficit disorder without mention of hyperactivity 444 45 225 5
Depressive disorder: not elsewhere classified 2221 50 225 5
Dysthymic disorder 752 50 225 5
Tachycardia: unspecified 631 45 225 5
Degeneration of cervical intervertebral disc 904 56 337 6
Flatulence: eructation: and gas pain 427 45 225 5
Generalized anxiety disorder 833 45 225 5
Other symptoms referable to back 368 50 300 5
Cellulitis and abscess of leg: except foot 450 45 225 5
Constipation: unspecified 1136 45 225 5
Thoracic or lumbosacral neuritis or radiculitis: unspecified 1676 60 326 6
Anxiety state: unspecified 2205 50 225 5
Lumbago 4559 50 250 5
Abdominal pain: generalized 1607 45 225 5
Degeneration of lumbar or lumbosacral intervertebral disc 1542 60 388 6
Other and unspecified noninfectious gastroenteritis and colitis 1254 45 225 5
Major depressive affective disorder: recurrent episode: moderate 507 45 225 5
Asthma: unspecified type: unspecified 2044 45 225 5
Arthrodesis status 178 60 450 7
Chest pain: unspecified 4701 45 225 5
Characterization of Overlap in Observational Studies
Routine general medical examination at a health care facility 9529 50 225 5
Diarrhea 1714 50 225 5
Fitting and adjustment of vascular catheter 318 45 225 5
Hypopotassemia 721 45 225 5
Bariatric surgery status 302 40 200 5
Sprain of neck 816 50 225 5
Unspecified gastritis and gastroduodenitis: without mention of hemorrhage 960 45 225 5
Injury of face and neck 271 46 300 5
Backache: unspecified 2471 50 225 5
Unspecified septicemia 222 45 225 5
Acute pharyngitis 4219 45 225 5
Acute bronchitis 3311 46 225 5
Abdominal pain: other specified site 2890 45 225 5
Atrophic gastritis: without mention of hemorrhage 537 45 225 5
Cough 3946 45 225 5
Altered mental status 202 45 225 5
Cervicalgia 2758 50 250 5
Abdominal pain: unspecified site 6339 45 225 5
Other chronic pain 346 56 300 6
Headache 3514 45 225 5
Tobacco use disorder 1834 50 225 5
Other screening mammogram 5722 50 240 5
Observation and evaluation for other specified suspected conditions 337 45 225 5
Unspecified sinusitis (chronic) 1624 46 225 5
Rheumatoid arthritis 353 50 300 5
Brachial neuritis or radiculitis NOS 1147 50 300 5
Loss of weight 455 46 225 5
Hypersomnia with sleep apnea: unspecified 424 42 225 5
Insomnia: unspecified 968 50 225 5
Other malaise and fatigue 5178 46 225 5
Other injury of chest wall 210 50 300 5
Dehydration 841 45 225 5
Acute respiratory failure 120 40 225 5
Table S7: Population averages for the 156 features in the UTI cohort. Mean values and total (for binary features)
are given, and there are 64593 subjects in total.
Mean Total
Demographics
Age 55.1
Male 16.53% 10685
White 72.17% 46662
Veteran 4.61% 2981
Current Location
Outpatient 64.89% 41957
Emergency Room 15.69% 10142
Inpatient 17.26% 11159
Intensive Care Unit (ICU) 2.69% 1736
Local Resistance Rates (Past 30-90 days, at this location)
Trimethoprim/Sulfamethoxazole 18.61%
Nitrofurantoin 19.85%
Ciprofloxacin 22.70%
Levofloxacin 24.19%
Secondary Site of Infection
Skin / Soft Tissue 0.20% 132
Blood 1.59% 1031
Respiratory Tract 0.53% 341
Nasal or Rectal Swab 0.19% 124
Medical History (Past 90 Days)
Alcohol abuse 1.66% 1074
Deficiency anemia 2.84% 1837
Cardiac arrhythmias 17.08% 11041
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Blood loss anemia 0.49% 315
Congestive heart failure 10.16% 6571
Coagulopathy 3.81% 2466
Diabetes, uncomplicated 14.13% 9135
Diabetes, complicated 5.00% 3232
Depression 11.80% 7627
Drug abuse 1.72% 1114
Fluid and electrolyte disorders 13.84% 8946
AIDS/HIV 0.43% 281
Hypertension, uncomplicated 32.51% 21017
Hypertension, complicated 5.43% 3513
Hypothyroidism 7.86% 5085
Liver disease 4.36% 2822
Lymphoma 1.63% 1051
Metastatic cancer 5.50% 3559
Other neurological disorders 6.68% 4319
Obesity 6.70% 4332
Pulmonary circulation disorders 3.13% 2025
Peptic ulcer disease, excluding bleeding 0.61% 393
Peripheral vascular disorders 5.68% 3672
Paralysis 3.08% 1992
Psychoses 2.42% 1563
Chronic pulmonary disease 11.29% 7299
Renal 8.87% 5735
Rheumatoid arthritis / collagen vascular diseases 3.76% 2428
Solid tumor without metastasis 12.00% 7760
Valvular disease 7.79% 5034
Weight loss 3.59% 2319
Preganant 3.08% 1989
Previous Care (Past 90 days)
Inpatient Stay 18.38% 11882
Nursing Home Stay 1.20% 779
Previous Procedures (Past 90 days)
Central Venous Catheder 5.27% 3410
Hemodialysis 0.66% 427
Mechanical Ventilation 5.74% 3714
Parenteral Nutrition 0.67% 434
Surgery 59.84% 38689
Previous Organisms (Past 90 days)
Citrobacter species 0.42% 270
Coagulate negative Staphylococcus species 1.15% 741
Enterobacter aerogenes 0.15% 95
Escherichia coli 7.82% 5057
Enterococcus species 2.66% 1718
Enterobacter cloacae 0.29% 186
Group B Streptococcus 0.17% 109
Klebsiella pneumoniae 2.02% 1307
Morganella species 0.11% 73
Pseudomonas aeruginosa 0.92% 594
Proteus species 0.69% 445
Staph aureus 1.55% 1003
Serratia species 0.22% 145
Previous Resistance, measured by culture (Last 90 Days)
Amoxicillin Clavulanate 2.34% 1511
Amikacin 0.10% 67
Ampicillin 7.44% 4808
Aztreonam 0.95% 616
Ceftazidime 0.30% 197
Cefazolin 9.22% 5962
Chlorampenicol 0.17% 111
Ciprofloxacin 4.62% 2984
Clindamycin 0.97% 624
Ceftriaxone 1.24% 804
Doxycycline 0.39% 249
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Ertapenem 0.14% 88
Erythromycin 3.71% 2399
Cefepime 0.54% 351
Cefoxitin 0.49% 319
Gentamicin 1.65% 1066
Gentamicin (Synergistic) 0.47% 307
Imipenem 0.47% 303
Levofloxacin 5.32% 3439
Linezolid 0.09% 58
Meropenem 0.13% 85
Moxifloxacin 0.86% 556
Nalidixic Acid 0.09% 60
Nitrofurantoin 4.06% 2628
Oxacillin 1.79% 1158
Penicillin 2.41% 1559
Piperacillin 0.62% 402
Polymyxin B 1.22% 790
Rifampin 0.80% 518
Ampicillin Sulbactam 1.63% 1056
Streptomycin (Synergistic) 0.23% 150
Trimethoprim Sulfamethoxazole 3.10% 2006
Tetracycline 5.33% 3443
Ticarcillin 0.24% 153
Tobramycin 0.31% 203
Piperacillin Tazobactam 0.53% 341
Vancomycin 0.92% 598
Previous Antibiotic Prescription (Last 90 Days)
Amikacin 0.09% 60
Amoxicillin 2.47% 1596
Amoxicillin/Clavulanate 2.15% 1388
Amphotericin B 0.16% 102
Ampicillin/Sulbactam 0.34% 217
Azithromycin 2.86% 1847
Aztreonam 0.25% 159
Cefadroxil 0.15% 96
Cefazolin 4.87% 3150
Cefepime 2.30% 1489
Cefixime 0.26% 166
Cefotetan 0.18% 114
Cefoxitin 0.25% 161
Cefpodoxime 0.88% 570
Ceftazidime 0.73% 475
Ceftriaxone 2.75% 1775
Cefuroxime 0.24% 156
Cephalexin 2.31% 1496
Ciprofloxacin 11.09% 7170
Clarithromycin 0.35% 226
Clindamycin 1.84% 1187
Daptomycin 0.10% 63
Dicloxacillin 0.19% 126
Doxycycline 1.73% 1119
Ertapenem 0.22% 140
Erythromycin 0.39% 249
Fluconazole 3.56% 2301
Fosfomycin 0.36% 232
Gentamicin 0.94% 607
Imipenem 0.33% 216
Levofloxacin 5.94% 3838
Linezolid 0.73% 470
Meropenem 0.40% 256
Metronidazole 4.49% 2906
Micafungin 0.24% 154
Minocycline 0.20% 129
Moxifloxacin 0.27% 174
Nafcillin 0.24% 157
Nitrofurantoin 2.73% 1767
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Norfloxacin 4.25% 2749
Penicillin 0.31% 199
Piperacillin 0.41% 268
Piperacillin/Tazobactam 0.23% 148
Polymyxin B 0.52% 333
Posaconazole 0.18% 118
Tetracycline Metronidazole 0.09% 59
Trimethoprim 0.12% 79
Trimethoprim/Sulfamethoxazole 3.96% 2558
Vancomycin 8.80% 5690
Vancomycin Gentamicin 3.35% 2165
